<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9216904</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2419</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Genet.</journal-id>
<journal-title-group>
<journal-title>Nature genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1061-4036</issn>
<issn pub-type="epub">1546-1718</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30559488</article-id>
<article-id pub-id-type="pmc">6309590</article-id>
<article-id pub-id-type="doi">10.1038/s41588-018-0288-4</article-id>
<article-id pub-id-type="manuscript">NIHMS1510455</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neurodevelopmental disease genes implicated by <italic>de
novo</italic> mutation and copy number variation morbidity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Coe</surname>
<given-names>Bradley P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stessman</surname>
<given-names>Holly A.F.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sulovari</surname>
<given-names>Arvis</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geisheker</surname>
<given-names>Madeleine R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bakken</surname>
<given-names>Trygve E.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lake</surname>
<given-names>Allison M.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dougherty</surname>
<given-names>Joseph D.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lein</surname>
<given-names>Ed S.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hormozdiari</surname>
<given-names>Fereydoun</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernier</surname>
<given-names>Raphael A.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eichler</surname>
<given-names>Evan E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1)</label>Department of Genome Sciences, University of Washington
School of Medicine, Seattle, WA 98195, USA</aff>
<aff id="A2"><label>2)</label>Department of Pharmacology, Creighton University Medical
School, Omaha, NE 68178, USA</aff>
<aff id="A3"><label>3)</label>Allen Institute for Brain Science, Seattle, WA 98109,
USA</aff>
<aff id="A4"><label>4)</label>Department of Genetics, Department of Psychiatry,
Washington University School of Medicine, St. Louis, MO 63110, USA</aff>
<aff id="A5"><label>5)</label>Department of Biochemistry and Molecular Medicine,
University of California, Davis, Davis, CA 95817, USA</aff>
<aff id="A6"><label>6)</label>Department of Psychiatry and Behavioral Sciences,
University of Washington, Seattle, WA, USA</aff>
<aff id="A7"><label>7)</label>Howard Hughes Medical Institute, University of Washington,
Seattle, WA 98195, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">B.P.C. and E.E.E. designed the study. B.P.C. performed the primary
statistical data analysis. B.P.C., H.A.F.S., and M.R.G. curated DNMs and
performed enrichment analyses. A.S. assisted with statistical analyses and
interpretation. R.A.B. performed phenotype analysis. T.E.B. and E.S.L.
performed the human expression analysis. A.M.L. and J.D.D. performed CSEA on
cortex and assisted with additional CSEA/TSEA. F.H. performed the gene
network analysis. B.P.C. and E.E.E. wrote the manuscript. All authors have
read and approved the final version of the manuscript.</p>
</fn>
<corresp id="CR1"><label>*</label>Corresponding author: Evan E. Eichler, Ph.D.,
University of Washington School of Medicine, Howard Hughes Medical Institute,
3720 15th Ave NE, S413C, Seattle, WA 98195-5065, Phone: (206) 543-9526,
<email>eee@gs.washington.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>51</volume>
<issue>1</issue>
<fpage>106</fpage>
<lpage>116</lpage>
<!--elocation-id from pubmed: 10.1038/s41588-018-0288-4-->
<permissions>
<license>
<license-p>Users may view, print, copy, and download text and data-mine the
content in such documents, for the purposes of academic research, subject
always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
</license>
</permissions>
<abstract id="ABS1">
<p id="P3">We combined <italic>de novo</italic> mutation (DNM) data from 10,927
cases of developmental delay and autism to identify 253 candidate
neurodevelopmental disease genes with an excess of missense and/or likely
gene-disruptive mutations. Of these genes, 124 reach exome-wide significance (p
&lt; 5 × 10<sup>−7</sup>) for DNM. Intersecting these results
with copy number variation morbidity data shows an enrichment for genomic
disorder regions (30/253, LR+ 1.85, p = 0.0017). We identify genes with an
excess of missense DNMs overlapping deletion syndromes (e.g.,
<italic>KIF1A</italic> and the 2q37 deletion) as well as duplication
syndromes, such as recurrent <italic>MAPK3</italic> missense mutations within
the chromosome 16p11.2 duplication, recurrent <italic>CHD4</italic> missense
DNMs in the 12p13 duplication region, and recurrent <italic>WDFY4</italic>
missense DNMs in the 10q11.23 duplication region. Network analyses of genes
showing an excess of DNMs highlights functional networks, including
cell-specific enrichments in the D1+ and D2+ spiny neurons of the striatum.</p>
</abstract>
<kwd-group>
<kwd>Neurodevelopmental Disorders</kwd>
<kwd>Autism</kwd>
<kwd><italic>de novo</italic> Mutation</kwd>
<kwd>Genetics of Developmental Delay</kwd>
<kwd>KCNQ2</kwd>
<kwd>PACS1</kwd>
<kwd>PACS2</kwd>
<kwd>MAP2K1</kwd>
<kwd>KCNH1</kwd>
<kwd>GRIN2B</kwd>
<kwd>PPP2R5D</kwd>
<kwd>CTCF</kwd>
<kwd>BCL11A</kwd>
<kwd>SETBP1</kwd>
<kwd>ARID1B</kwd>
<kwd>DNMT3A</kwd>
<kwd>ZMYND11</kwd>
<kwd>SMARCD1</kwd>
<kwd>MECP2</kwd>
<kwd>KAT6B</kwd>
<kwd>WDR26</kwd>
<kwd>PTPN11</kwd>
<kwd>CDK13</kwd>
<kwd>TBL1XR1</kwd>
<kwd>TCF4</kwd>
<kwd>SNX5</kwd>
<kwd>HNRNPU</kwd>
<kwd>TNPO2</kwd>
<kwd>STXBP1</kwd>
<kwd>ITPR1</kwd>
<kwd>DYRK1A</kwd>
<kwd>CHD2</kwd>
<kwd>SOX5</kwd>
<kwd>KCNQ3</kwd>
<kwd>TRIP12</kwd>
<kwd>TAF1</kwd>
<kwd>KAT6A</kwd>
<kwd>CSNK2A1</kwd>
<kwd>PUF60</kwd>
<kwd>CUL3</kwd>
<kwd>FOXP1</kwd>
<kwd>GNAO1</kwd>
<kwd>SMARCA2</kwd>
<kwd>MYT1L</kwd>
<kwd>GNAI1</kwd>
<kwd>ADAP1</kwd>
<kwd>FOXG1</kwd>
<kwd>SMC1A</kwd>
<kwd>PPP2R1A</kwd>
<kwd>GABRB2</kwd>
<kwd>EEF1A2</kwd>
<kwd>NAA10</kwd>
<kwd>HDAC8</kwd>
<kwd>ADNP</kwd>
<kwd>KMT2A</kwd>
<kwd>PIK3CA</kwd>
<kwd>PTEN</kwd>
<kwd>IQSEC2</kwd>
<kwd>MEF2C</kwd>
<kwd>SMARCA4</kwd>
<kwd>COL4A3BP</kwd>
<kwd>CAPN15</kwd>
<kwd>PURA</kwd>
<kwd>CHD3</kwd>
<kwd>WDR45</kwd>
<kwd>DLX3</kwd>
<kwd>TMEM178A</kwd>
<kwd>MED13L</kwd>
<kwd>ZBTB18</kwd>
<kwd>TLK2</kwd>
<kwd>DYNC1H1</kwd>
<kwd>POGZ</kwd>
<kwd>SLC6A1</kwd>
<kwd>EP300</kwd>
<kwd>SYNGAP1</kwd>
<kwd>DDX3X</kwd>
<kwd>SATB2</kwd>
<kwd>AGO4</kwd>
<kwd>SCN2A</kwd>
<kwd>BRAF</kwd>
<kwd>EHMT1</kwd>
<kwd>NSD1</kwd>
<kwd>NFIX</kwd>
<kwd>CREBBP</kwd>
<kwd>SRCAP</kwd>
<kwd>TRIO</kwd>
<kwd>PPP1CB</kwd>
<kwd>USP9X</kwd>
<kwd>CASK</kwd>
<kwd>SCN8A</kwd>
<kwd>CHD8</kwd>
<kwd>EFTUD2</kwd>
<kwd>SNAPC5</kwd>
<kwd>KDM5B</kwd>
<kwd>HECW2</kwd>
<kwd>KIF1A</kwd>
<kwd>SETD5</kwd>
<kwd>RAC1</kwd>
<kwd>SUV420H1</kwd>
<kwd>ANP32A</kwd>
<kwd>KANSL1</kwd>
<kwd>MEIS2</kwd>
<kwd>NONO</kwd>
<kwd>HIVEP3</kwd>
<kwd>ANKRD11</kwd>
<kwd>ASXL3</kwd>
<kwd>CTNNB1</kwd>
<kwd>AHDC1</kwd>
<kwd>GATAD2B</kwd>
<kwd>TCF20</kwd>
<kwd>SHANK3</kwd>
<kwd>ENO3</kwd>
<kwd>ASH1L</kwd>
<kwd>CHAMP1</kwd>
<kwd>PPM1D</kwd>
<kwd>KIAA2022</kwd>
<kwd>LEO1</kwd>
<kwd>CAPRIN1</kwd>
<kwd>CNKSR2</kwd>
<kwd>MSL3</kwd>
<kwd>MBD5</kwd>
<kwd>NAA15</kwd>
<kwd>SYNCRIP</kwd>
<kwd>QRICH1</kwd>
<kwd>DLG4</kwd>
<kwd>UPF3B</kwd>
<kwd>SET</kwd>
<kwd>WAC</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1">
<title>INTRODUCTION</title>
<p id="P4">The importance of <italic>de novo</italic> mutations (DNMs) underlying
neurodevelopmental disorders (NDDs) has been recognized for many years. Some of the
strongest genome-wide evidence came from early copy number variation (CNV) studies,
which consistently showed an excess of <italic>de novo</italic> as well as large
private CNVs in patients with autism, developmental delay (DD) and
epilepsy<sup><xref ref-type="bibr" rid="R1">1</xref>-<xref ref-type="bibr" rid="R4">4</xref></sup>. Significance based on CNV recurrence was
more readily achieved from smaller sample sizes because of elevated mutation rates
in regions flanked by segmental duplications<sup><xref ref-type="bibr" rid="R5">5</xref></sup> or hotspots of recurrent rearrangement near
telomeres<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. In many cases
the individual genes underlying the genomic disorders remain unknown.</p>
<p id="P5">The advent of next-generation sequencing and exome sequencing rapidly
accelerated our ability to specify genes associated with potentially pathogenic
<italic>de novo</italic> single-nucleotide variants (SNVs) for both DD and
autism<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup>, although recurrent mutations occurred more
rarely<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref></sup>. Different statistical models for discovery
of genes based on recurrent SNV mutation have been developed, including those based
on chimpanzee-human divergence<sup><xref ref-type="bibr" rid="R11">11</xref></sup>,
trinucleotide mutation context<sup><xref ref-type="bibr" rid="R12">12</xref></sup>,
and clustering of DNMs<sup><xref ref-type="bibr" rid="R13">13</xref>-<xref ref-type="bibr" rid="R15">15</xref></sup>. Despite extensive CNV analyses of nearly
45,000 patients with autism and DD<sup><xref ref-type="bibr" rid="R16">16</xref>-<xref ref-type="bibr" rid="R18">18</xref></sup>, few attempts
have been made<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup> to integrate the wealth of CNV data with
recent exome sequencing results despite a common mutational model of dosage
imbalance.</p>
<p id="P6">In this study, we perform an integrated meta-analysis combining DNM exome
sequence data from individuals with autism spectrum disorder (ASD), intellectual
disability (ID) and/or DD<sup><xref ref-type="bibr" rid="R20">20</xref></sup> with
CNV morbidity data. Because of the significant comorbidity between ID and
ASD<sup><xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22">22</xref></sup> and the fact that autism cases with a severe
DNM are enriched in DD<sup><xref ref-type="bibr" rid="R23">23</xref></sup>, we
overlay these data with known genomic disorders. The goals of this study are
threefold: 1) provide an integrated list of candidate NDD genes based on multiple
lines of DNM and CNV evidence, 2) compare different models of recurrent mutation,
and 3) identify the most likely genes underlying pathogenic microdeletion and
microduplication CNVs associated with DD.</p>
</sec>
<sec id="S2">
<title>RESULTS</title>
<sec id="S3">
<title>Genes enriched for <italic>de novo</italic> SNV mutation and model
comparisons:</title>
<p id="P7">We compile <italic>de novo</italic> variation identified from exome
sequencing of 10,927 cases with NDDs from the denovo-db v.1.5 database
release<sup><xref ref-type="bibr" rid="R20">20</xref></sup>. This
includes 5,624 cases with a primary diagnosis of ASD and 5,303 cases with a
diagnosis of ID/DD collected from 17 studies<sup><xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R23">23</xref>-<xref ref-type="bibr" rid="R38">38</xref></sup> (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>). We consider
all protein-altering and likely gene-disruptive (LGD) mutations, including
frameshifts, splice donor/acceptor mutations, start losses and stop gains. The
combined set of 12,172 DNMs includes 2,357 LGD and 9,815 missense mutations.</p>
<p id="P8">We initially applied two statistical models. The first incorporates
locus-specific transition/transversion/indel rates and chimpanzee-human coding
sequence divergence<sup><xref ref-type="bibr" rid="R11">11</xref></sup> to
estimate the number of expected DNMs, hereafter referred to as the
chimpanzee-human divergence model or the CH model. The second model,
denovolyzeR<sup><xref ref-type="bibr" rid="R12">12</xref></sup>,
estimates mutation rates based using trinucleotide context and incorporates
exome depth and divergence adjustments based on macaque-human comparisons over a
±1 Mbp window and accommodates known mutational biases, such as CpG
hotspots. Both models apply their underlying mutation rate estimates to generate
prior probabilities for observing a specific number and class of mutations for a
given gene. While both models incorporate LGD and missense probabilities, we
recently modified the CH model to incorporate CADD scores<sup><xref ref-type="bibr" rid="R39">39</xref>,<xref ref-type="bibr" rid="R40">40</xref></sup> allowing us to also specifically test for enrichment for
the missense subset of the predicted most severe 0.1% of mutations (i.e., CADD
scores over 30 or MIS30). Such missense mutations are more likely to be
functionally equivalent to an LGD mutation and have been shown to be
significantly enriched in NDD cases compared to controls<sup><xref ref-type="bibr" rid="R14">14</xref></sup>. To account for the sensitivity biases,
we applied an upper bound baseline mutation rate assumption of 1.8 DNMs (derived
from high-coverage genome sequencing data) to the CH model, which exceeds the
overall DNM rate of this cohort.</p>
<p id="P9">Combined, the two models (union set) identify 253 candidate NDD genes
with evidence of excess DNM at a false discovery rate (FDR) &lt;5% and at
least two mutations for at least one mutational category (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="table" rid="T2">Table
2</xref>). This includes 145 genes with excess LGD mutations and 123 genes
with excess missense mutations. Among these, 29 genes demonstrate evidence of
both LGD and missense mutations (<xref ref-type="fig" rid="F1">Figure 1</xref>,
<xref ref-type="table" rid="T1">Table 1</xref>, and <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>). In general,
both models highlight similar genes (<xref ref-type="fig" rid="F1">Figure
1</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary
Note</xref>), particularly for LGD events where 73.1% (106/145) of genes are
shared. This stands in contrast to recurrent missense DNMs where only 51.2%
(63/123) of the genes overlap between the models suggesting that additional
model refinement is required to more accurately predict pathogenic missense
mutations. A more stringent application of the exome-wide Bonferroni family-wise
error rate (FWER) identifies a union of 124 genes (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Note</xref>).</p>
<p id="P10">We identified additional evidence of disease association, from a
comprehensive database and PubMed literature search, for 204/253 genes (Methods)
indicating that 49/253 union genes (10/124 FWER union genes) presented here are
novel associations (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 3</xref>). Of these
novel genes, 61% (30/49) demonstrate DNM in both ASD and ID/DD patients. We wish
to note that neither FDR nor FWER, however, are metrics of pathogenicity but
rather simply thresholds of significance to identify genes for further
investigation.</p>
<p id="P11">Since it has been well established that NDD genes are less tolerant to
mutation, we categorize the 253 genes into different functional groups and
compare their tolerance to mutation in the general population using three
metrics: residual variance to intolerance score (RVIS); probability of
loss-of-function intolerance (pLI); and missense constraint scores (missense Z
scores). For both pLI and missense Z scores, we utilized the ExAC subset with
known neuropsychiatric cohorts removed (45,376 individuals)<sup><xref ref-type="bibr" rid="R41">41</xref></sup>. For genes with an enrichment of LGD
variants, we observe a significant increase in pLI scores compared to all other
genes (p = 8.3 × 10<sup>−58</sup> two-tailed Wilcoxon rank-sum
test, ROC AUC = 0.90) (<xref ref-type="fig" rid="F1">Figure 1E</xref>). We also
observe a significant increase in missense constraint (missense Z scores) among
genes with enrichment for missense variation (p = 1.9 ×
10<sup>−44</sup> two-tailed Wilcoxon rank-sum test, ROC AUC = 0.87)
(<xref ref-type="fig" rid="F1">Figure 1F</xref>). Similarly, we observe a
significant RVIS depletion for all categories where at least two genes were
identified (<xref ref-type="fig" rid="F1">Figure 1G</xref>).</p>
<p id="P12">Examination of a combination of constraint metrics is particularly
valuable as a small number of genes demonstrate conflicting results, such as the
LGD- and missense-enriched gene <italic>MEF2C</italic>, which is involved in
severe ID when disrupted by deletions or mutations<sup><xref ref-type="bibr" rid="R42">42</xref></sup> and demonstrates constraint by RVIS, but
not by pLI (RVIS = 18.97, pLI = 2.4 × 10<sup>−3</sup>, missense Z
score = 4.47). Interestingly, among genes without pLI or RVIS support, we
identified established ASD/ID genes in addition to the expected potential false
positives. Among the union genes 82.6% (209/253) have no detected LGD or
missense DNM in controls (n = 2,278 controls; <xref ref-type="supplementary-material" rid="SD2">Supplementary Note</xref>). The detection
of control events may represent incomplete penetrance, variable expressivity,
undiagnosed/subclinical controls, or benign variation (primarily in the case of
missense variation). None of the recurrent control DNM genes reach exome-wide
FDR significance. While some of these are plausible candidates, disease
significance should be considered with caution until additional functional and
clinical data establish their role.</p>
</sec>
<sec id="S4">
<title>ASD versus ID/DD genes:</title>
<p id="P13">We investigated the distribution of LGD and missense mutations between
the ASD and ID/DD cohorts. The majority of this NDD gene set (68.4% (173/253) of
the union and 72.3% (107/148) of the intersection) show evidence of DNM in both
ASD and ID/DD cohorts, highlighting the utility of joint analyses. Although a
small number of genes are specific or enriched for a diagnosis of ID/DD (q
&lt; 0.01, one-tailed Fisher’s exact test), none are yet
statistically enriched for ASD (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>). A few
genes (<italic>WDFY3</italic>, <italic>DSCAM</italic> and <italic>CHD8</italic>)
trend toward ASD diagnosis. To eliminate potential ascertainment bias in
discovery, we repeated the overlap analysis considering gene discovery
independently in each cohort (<xref ref-type="supplementary-material" rid="SD2">Supplementary Note</xref>). Considering all 253 genes and the full set of
NDD patients, we calculate that 17.7% (1,932/10,927) of the samples have at
least one <italic>de novo</italic> event in this gene set.</p>
<p id="P14">The proportion of patients with a DNM is significantly higher for ID/DD
(26.8% or 1,421/5,303 patients) when compared to ASD (9.1% or 511/5,624
patients) (OR = 3.66, p = 1.62 × 10<sup>−133</sup>, two-tailed
Fisher’s exact test). While this may be partially biased by the
differences in DNM sensitivity between exome studies, this observation exceeds
the baseline 1.58-fold excess of LGD DNM in ID/DD cohorts and thus reflects
differences in heterogeneity between the disorders. Further supporting this bias
of LGD events to ID/DD, Simons Simplex Collection (SSC) autism probands who
carried an LGD DNM in one of the LGD genes were less likely to be
high-functioning. Instead, there was an overrepresentation of ID (≤70 IQ,
expected 753/2,445, observed 42/95) and low-to-normal IQ ranges (70 &lt; IQ
&lt; 100, expected 1,018/2,445, observed 45/95) compared to the high IQ
probands (≥100 IQ, expected 674/2,445, observed 8/95) (p = 4.0 ×
10<sup>−5</sup>, two-tailed likelihood ratio test) (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 4</xref>). Among the
autism mutation carriers, we observe a nominal enrichment for increased severity
of repetitive behavior (RBS-R [t(18) = 3.12, corrected p = 0.048], two-tailed
independent samples t-test) but were overall underpowered to further disentangle
associated phenotypic features.</p>
</sec>
<sec id="S5">
<title>Network enrichment and patterns of brain expression:</title>
<p id="P15">Examination of the 253 genes identified by the union of both statistical
approaches suggests that our set is strongly enriched for functionally related
networks of genes. The STRING database, for example, identifies a highly
significant 1.8-fold (1,067 edges vs. 573 expected) enrichment in interactions
among the 253 union genes (p &lt; 1.0 × 10<sup>−16</sup>,
one-tailed hypergeometric test). Given this high level of interconnectivity, we
applied MAGI<sup><xref ref-type="bibr" rid="R43">43</xref></sup>, a gene network
discovery tool, to identify potential gene clusters, functional enrichments, and
additional candidate interactions and highlight the top four protein-protein
interaction (PPI) and co-expression networks (each at p &lt; 0.01,
one-tailed permutation test) and their associated PANTHER functional enrichments
(<xref ref-type="fig" rid="F2">Figure 2A-D</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Tables 5</xref>-<xref ref-type="supplementary-material" rid="SD3">7</xref>).</p>
<p id="P16">Module 1 (20 genes) delineates “regulation of transcription from
RNA polymerase II promoter” (p = 0.0269, one-tailed Bonferroni adjusted
binomial test) (<xref ref-type="fig" rid="F2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Tables 5</xref>-<xref ref-type="supplementary-material" rid="SD3">7</xref>) and contains 15
significant genes in addition to three candidates that do not yet reach
significance (<italic>CREB1</italic>, <italic>RBBP5</italic>,
<italic>CBX5</italic>) and two genes (<italic>SREK1</italic>,
<italic>SMARCB1</italic>) with no DNM in our current data set. Module 2
highlights multiple functions relating to neurotransmitter signaling (p =
0.0358; one-tailed Bonferroni adjusted binomial test) and synaptic signaling (p
= 8.91 × 10<sup>−5</sup>, one-tailed Bonferroni adjusted binomial
test) (<xref ref-type="fig" rid="F2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Tables 5</xref>-<xref ref-type="supplementary-material" rid="SD3">7</xref>) and contains nine
significant genes in addition to ten genes that do not reach significance
(<italic>DLG2</italic>, <italic>HTT</italic>, <italic>AP2A2</italic>,
<italic>AP2M1</italic>, <italic>KCNJ4</italic>, <italic>KCNB1</italic>,
<italic>STX1A</italic>, <italic>GRIN2A</italic>, <italic>GRIN1</italic>,
<italic>CAMK2A</italic>) and one gene with no DNM (<italic>PRKCB</italic>).
Module 3 highlights the “transmembrane receptor protein serine/threonine
kinase signaling pathway” (p = 0.002; one-tailed Bonferroni adjusted
binomial test) (<xref ref-type="fig" rid="F2">Figure 2C</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Tables 5</xref>-<xref ref-type="supplementary-material" rid="SD3">7</xref>) and contains eight
significant genes in addition to 21 genes that do not reach significance
(<italic>SMURF2</italic>, <italic>SMURF1</italic>, <italic>CDC73</italic>,
<italic>RNPS1</italic>, <italic>RBBP4</italic>, <italic>UBE3A</italic>,
<italic>CUL1</italic>, <italic>CHMP1A</italic>, <italic>FBXW11</italic>,
<italic>VCP</italic>, <italic>VPS4A</italic>, <italic>PPP5C</italic>,
<italic>PRPF38A</italic>, <italic>SKIL</italic>, <italic>HSPA4</italic>,
<italic>PSMD3</italic>, <italic>UIMC1</italic>, <italic>GAPVD1</italic>,
<italic>NLGN2</italic>, <italic>GTF3C1</italic>, <italic>NRXN1</italic>) and
six genes with no DNM (<italic>ING2</italic>, <italic>SRSF4</italic>,
<italic>FAF1</italic>, <italic>UBC</italic>, <italic>HSP90AB1</italic>,
<italic>YWHAB</italic>). Finally, Module 4 highlights c-Jun N-terminal
kinase (JNK) (p = 4.65 × 10<sup>−5</sup>, one-tailed Bonferroni
adjusted binomial test) and mitogen-activated protein kinase (MAPK) (p = 3.13
× 10<sup>−6</sup>, one-tailed Bonferroni adjusted binomial test)
cascades (<xref ref-type="fig" rid="F2">Figure 2D</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Tables 5</xref>-<xref ref-type="supplementary-material" rid="SD3">7</xref>) and contains two
significant genes in addition to 15 genes that do not reach significance
(<italic>RPS6KA3</italic>, <italic>RASGRF1</italic>,
<italic>MAPK8IP1</italic>, <italic>SMAD3</italic>, <italic>DUSP3</italic>,
<italic>MAPK9</italic>, <italic>SPTBN1</italic>, <italic>ACTN4</italic>,
<italic>CAMK2G</italic>, <italic>TFE3</italic>, <italic>PRKAR1A</italic>,
<italic>SNAP25</italic>, <italic>MAPK8IP2</italic>,
<italic>MAPK8IP3</italic>, <italic>PRKAR1B</italic>) and three genes with no
DNM (<italic>SYN1</italic>, <italic>MAPK1</italic>, <italic>PRKACA</italic>).
Among these nonsignificant genes are many previously identified NDD candidate
genes (e.g., <italic>NRXN1</italic>, <italic>GRIN2A</italic>,
<italic>CAMK2A</italic>)<sup><xref ref-type="bibr" rid="R44">44</xref>-<xref ref-type="bibr" rid="R46">46</xref></sup> suggesting this group as a
potential target for future screening and disease gene discovery.</p>
<p id="P17">In addition to enrichment in the PPI context, we also note functional
cell-specific and tissue-specific enrichment analyses (CSEA and TSEA)<sup><xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup> obtained primarily from mouse expression data sets. As
expected, the 253 gene set is enriched for the brain expression with a bias
toward early to mid-fetal gene expression in the cortex, striatum and amygdala
(<xref ref-type="fig" rid="F2">Figure 2E</xref>). Among these, the greatest
specificity is observed for early to early mid-fetal cortical development. By
CSEA, the <italic>de novo</italic> gene set shows enrichment in both classes of
medium spiny neurons within the striatum (striatum D1+ and D2+ medium spiny
neurons Benjamini-Hochberg (BH)-corrected p = 0.013 and p = 0.011, one-tailed
Fisher’s exact test) at a pSI (specificity index p-value) threshold of
0.05. Additionally, we observe nominal significance for D1+ and D2+ spiny
neurons (uncorrected p = 0.027 and p = 0.023, one-tailed Fisher’s exact
test) at a pSI of 0.01 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2A</xref>), and through a further analysis of
available single-cell sequencing data, two pyramidal neuron subtypes (S1PyrL5,
BH p = 0.008; one-tailed Fisher’s exact test) and the hippocampus
(CA1Pyr1, BH p = 0.046; one-tailed Fisher’s exact test) (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2B</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Note</xref>).</p>
<p id="P18">As a final analysis, we also assess the expression patterns of the union
gene set using human RNA-seq data sets. The gene set, irrespective of class of
mutation, is significantly enriched for a pan-neuronal pattern of expression
when compared to control sets selected based on synonymous DNM in cases and
genes with recurrent DNM in controls samples (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>). This analysis does not highlight specific
cell types when compared to control genes (p = 0.52, two-tailed corrected
Wilcoxon rank-sum test) but does show slightly higher expression across neuronal
cell types (p = 0.0001; two-tailed corrected Wilcoxon rank-sum test) even after
controlling for gene length (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>). The 253 union gene set shows a strikingly
broad expression profile across adult human cortical neuron types, including
GABAergic (inhibitory) and glutamatergic (excitatory) neurons, compared to
control genes (<xref ref-type="fig" rid="F3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Note</xref>).</p>
</sec>
<sec id="S6">
<title>Projected rates of gene discovery:</title>
<p id="P19">Based on the number of genes that reach significance for DNM in our
cohort of 10,927 cases, we estimate the potential yield by mutational class and
the CH model. To this end, we subsampled smaller populations from our set 10,000
times each and tested for how many genes would reach significance using the CH
model in a resampled cohort. We assess logistic growth models for each mutation
class and select the best fitting model by Bayesian information criteria (BIC)
to predict future performance. For genes with excess LGD DNMs, we observe what
appears to be a rapid upcoming plateau in gene discovery with an asymptote at
216 genes (95% CI 208-225) (ΔBIC linear model - asymptotic regression
model = 259) (<xref ref-type="fig" rid="F4">Figure 4</xref>). Similarly, for
genes with an excess of MIS30 DNMs, the model predicts an asymptote of only 65
genes (95% CI 63-67) (ΔBIC linear model - Weibull model = 250) (<xref ref-type="fig" rid="F4">Figure 4</xref>). By contrast, genes with an excess
of recurrent missense mutations cannot yet be projected (<xref ref-type="supplementary-material" rid="SD2">Supplementary Note</xref>).</p>
</sec>
<sec id="S7">
<title>CNV intersection:</title>
<p id="P20">In order to identify potentially dosage-sensitive genes underlying
pathogenic CNVs, we intersect the 253 candidate gene set with a list of 58
genomic disorders based on previous CNV morbidity maps and the DECIPHER database
(<xref ref-type="table" rid="T3">Table 3</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>, <xref ref-type="fig" rid="F5">Figure 5</xref>). Considering all genes with a
<italic>de novo</italic> variant (n = 6,886), we find that 30 of 253
significant genes intersect a genomic disorder region, compared to 426 of 6,633
non-significant genes intersecting a disorder. This represents a significant (p
= 0.0017, two-tailed Fisher’s exact test) enrichment (LR+ 1.85 [95% CI
1.38 - 2.43]) compared to expectations supporting the notion that
neurodevelopmental CNVs and DNMs converge on a common genetic etiology of
gene-dosage imbalance. While we are underpowered to detect enrichment for any
specific mutational and CNV class interactions by post-hoc testing, as expected
LGD-significant genes and deletion disorders demonstrated the strongest
enrichment among the four combinations (p = 0.1, two-tailed Fisher’s
exact test, LR+ = 1.77 [95% CI 1.2 - 2.54]). Given the known complexity of gene
regulation in CNVs<sup><xref ref-type="bibr" rid="R49">49</xref></sup>, we
highlight candidates representing all interaction types (<xref ref-type="table" rid="T3">Table 3</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>) with the
expectation that the strongest candidates will correspond to a simple model of
haploinsufficiency.</p>
<p id="P21">Many genomic disorders intersect with a single DNM-enriched gene,
confirming a known CNV gene association, including <italic>KANSL1</italic>
(Koolen-de Vries)<sup><xref ref-type="bibr" rid="R50">50</xref></sup>,
<italic>SHANK3</italic> (Phelan-McDermid)<sup><xref ref-type="bibr" rid="R51">51</xref></sup>, <italic>RAI1</italic>
(Smith-Magenis)<sup><xref ref-type="bibr" rid="R52">52</xref></sup>,
<italic>NSD1</italic> (Sotos)<sup><xref ref-type="bibr" rid="R53">53</xref></sup>, <italic>WHSC1</italic> (Wolf-Hirschhorn)<sup><xref ref-type="bibr" rid="R54">54</xref></sup>, <italic>BCL11A</italic>
(2p15-16.1 microdeletion)<sup><xref ref-type="bibr" rid="R55">55</xref></sup>,
<italic>EHMT1</italic> (9q34 deletions / Kleefstra syndrome)<sup><xref ref-type="bibr" rid="R56">56</xref></sup>, and <italic>CREBBP</italic>
(Rubinstein-Taybi)<sup><xref ref-type="bibr" rid="R57">57</xref></sup>
(<xref ref-type="table" rid="T3">Table 3</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>). In
addition, this analysis also highlights genes that have been implicated as
candidates by case reports, functional studies, or smaller CNVs (<xref ref-type="table" rid="T3">Table 3</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>). Among
these, we identify an excess of recurrent missense mutation in
<italic>MAPK3</italic> mapping to the 16p11.2 microdeletion/microduplication
region associated with ASD and ID<sup><xref ref-type="bibr" rid="R58">58</xref></sup>. Recurrent LGD mutations in <italic>PHF21A</italic>, a gene
previously implicated by translocations and focal CNVs<sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup>, map to the Potocki-Shaffer deletion region, while an
excess of missense mutations in <italic>KIF1A</italic> correspond to the 2q37
deletion syndrome region<sup><xref ref-type="bibr" rid="R61">61</xref>,<xref ref-type="bibr" rid="R62">62</xref></sup>. Recurrent LGD DNMs in
<italic>SIN3A</italic>, a REST and MECP2 interactor, map to the 15q24
deletion region<sup><xref ref-type="bibr" rid="R63">63</xref>-<xref ref-type="bibr" rid="R65">65</xref></sup>. <italic>PPM1D</italic> has been linked
to ID<sup><xref ref-type="bibr" rid="R66">66</xref></sup> and is located in the
17q23.1q23.2 deletion region. <italic>CLTC</italic> has been linked to multiple
malformations and DD and is located in the 17q23 deletion region<sup><xref ref-type="bibr" rid="R67">67</xref></sup>. Genes enriched for recurrent
missense DNM, <italic>YWHAG</italic> and <italic>GABRB3</italic>, co-localize to
the Williams-Beuren distal and Prader-Willi deletion/duplication regions,
respectively<sup><xref ref-type="bibr" rid="R68">68</xref>-<xref ref-type="bibr" rid="R70">70</xref></sup>.</p>
<p id="P22">Finally, we also consider as part of this analysis the 14 regions
identified as significant for CNV burden<sup><xref ref-type="bibr" rid="R18">18</xref></sup> and identify five candidate intersections (<xref ref-type="table" rid="T3">Table 3</xref>). These include
<italic>SATB2</italic> in the 2q33.1 region <sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R71">71</xref></sup>; <italic>MEF2C</italic>, which demonstrated focal
deletions, functions at cortical synapses and has been independently linked to
hyperkinesis and epilepsy<sup><xref ref-type="bibr" rid="R72">72</xref>,<xref ref-type="bibr" rid="R73">73</xref></sup>; <italic>CHD4</italic> in the
12p13 duplication region, which has been linked by both a genome-wide
association study (GWAS) and DNM to an ID syndrome<sup><xref ref-type="bibr" rid="R74">74</xref>,<xref ref-type="bibr" rid="R75">75</xref></sup>; and <italic>WDFY4</italic> in the 10q11.23 duplication
region, which appears to be a novel finding at this time.</p>
<p id="P23">A second category of CNVs are those that intersect more than a single
gene (<xref ref-type="table" rid="T3">Table 3</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>). The 2q33.1
region contains several potentially high-impact candidates, including
<italic>HECW2</italic>, which has been linked to neurodevelopmental delay,
ID and epilepsy by missense mutations<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R76">76</xref></sup>;
<italic>SATB2</italic>, which has been independently identified by focal
CNVs<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R71">71</xref></sup>; <italic>ABI2</italic>, which is a
candidate for autosomal recessive ID<sup><xref ref-type="bibr" rid="R77">77</xref></sup>; and <italic>SF3B1</italic>, which interacts directly
with the ID gene <italic>PQBP1</italic><sup><xref ref-type="bibr" rid="R78">78</xref></sup>. Similarly, in the 2p15-p16.1 deletion region we
identify both the primary gene <italic>BCL11A</italic><sup><xref ref-type="bibr" rid="R55">55</xref></sup> as well as a second candidate gene in
the minimal critical region, <italic>PAPOLG</italic><sup><xref ref-type="bibr" rid="R79">79</xref></sup>, which is enriched for severe missense
DNM. Finally, in the 2q11.2q13 deletion region we identify both
<italic>POU3F3</italic>, which has been linked to ID and dysmorphic features
by focal deletions<sup><xref ref-type="bibr" rid="R80">80</xref></sup>, and
<italic>RFX8</italic>, which has limited functional information in the
literature.</p>
</sec>
</sec>
<sec id="S8">
<title>DISCUSSION</title>
<p id="P24">Exome sequencing of parent-child trios is a particularly powerful tool for
the identification of genes, which when disrupted lead to pediatric NDD. The use of
two DNM models, CH model and denovolyzeR, identifies a high-confidence intersection
(n = 148 genes) and a comprehensive union set (253 genes), which reach significance
by one or both models. An advantage of using both is that we identify high-risk
candidate genes unique to each model (n = 75 additional genes), including several
where DNMs have already been associated with neurodevelopmental disease. Examination
of this gene set in the context of general population (i.e., ExAC) confirms that
this set list is enriched for genes that are constrained in the general population
(LGD pLI p = 8.3 × 10<sup>−58</sup>, missense Z score p = 1.9 ×
10<sup>−44</sup>, two-tailed Wilcoxon rank-sum test, RVIS p &lt; 1
× 10<sup>−7</sup> to 2.0 × 10<sup>−2</sup>, Bonferroni
adjusted Tukey HSD test) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p id="P25">While intolerance metrics are useful to enrich for pathogenic genes, our
analysis suggests caution in strict application of a specific cutoff or even a
single metric. Several known pathogenic genes are borderline by only one intolerance
score, while several are poorly constrained by both metrics (e.g.,
<italic>MECP2</italic> and Rett syndrome; RVIS = 32.4, pLI = 0.66). For example,
we identify 20 genes that are intolerant to mutation by pLI but not RVIS (RVIS
&gt; 20). Some of these are well-established genes (e.g.,
<italic>KANSL1</italic> and the Koolen-de Vries syndrome)<sup><xref ref-type="bibr" rid="R50">50</xref></sup> and the basis for this discrepancy is
unknown but may relate to the fact that part of the gene is duplicated complicating
genome-wide analyses of intolerance. Among targets poorly constrained by both
metrics, the Bohring-Opitz syndrome gene, <italic>ASXL1</italic>, was recently
highlighted for the presence of somatic mosaic variants in the ExAC population (from
which both the RVIS and pLI score are derived)<sup><xref ref-type="bibr" rid="R81">81</xref></sup>.</p>
<p id="P26">Our projection estimates indicate that gene discovery based on recurrent LGD
or severe missense mutations (MIS30) will soon plateau (<xref ref-type="fig" rid="F3">Figure 3</xref>). Clinical interpretation of patients with the
only DNM in a previously unobserved gene will remain a challenge. Partitioning
patients based on additional phenotypic criteria, sub-selecting genes based on
functional pathway enrichment<sup><xref ref-type="bibr" rid="R43">43</xref></sup>,
integration of inherited variation (e.g., TADA)<sup><xref ref-type="bibr" rid="R82">82</xref></sup>, or targeting a small number of genes in much larger
cohorts<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref></sup> are all potential strategies for associating
specific genes with a phenotype under these conditions. For example, analysis of
this set of DNMs in the context of MAGI modules further identified key functional
categories, including neurotransmitter/synaptic signaling and JNK/MAPK cascades.
This analysis identifies 46 genes with DNMs among the four modules that do not yet
reach significance but likely represent functionally important targets for future
screens.</p>
<p id="P27">In contrast to LGD and MIS30 DNM, the number of genes that will be
identified by missense DNM generally has not yet begun to approach an asymptote.
Samples sizes are just now beginning to reach the level where signatures of
recurrence and missense clustering are being detected for a relatively modest number
of genes—most of which are only nominally significant<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup>.
We propose that this class of mutation (less severe or clustered missense DNMs)
represents the most promising reservoir for future gene discovery but will require
much larger whole-exome and whole-genome data sets to tease apart. As the number of
exomes grows for both ASD and DD, the maintenance and curation of <italic>de
novo</italic> databases will be especially important in this regard<sup><xref ref-type="bibr" rid="R20">20</xref></sup>.</p>
<p id="P28">Previous studies have implicated larger CNVs and increased mutation burden
with more severe phenotypic outcomes and here we observe that the majority of DNM in
the 253 genes originates from ID/DD cases (&gt;3:1, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 8</xref>). Importantly,
DNM-enriched genes significantly overlap known pathogenic CNV regions (p = 0.0017,
two-tailed Fisher’s exact test, LR+ 1.85 [95% CI 1.38 - 2.43]) supporting a
common genetic etiology. These specific targets have offered both independent
confirmation of existing single-gene associations (e.g., <italic>KANSL1</italic> in
the 17q21.31 region), additional support for candidate genes (<italic>MAPK3</italic>
in the 16p11.2 region), and further support for potentially oligogenic effects with
multiple compelling candidate genes (<italic>HECW2</italic>, <italic>SATB2</italic>,
<italic>ABI2</italic>, and <italic>SF3B1</italic> in the 2q33.1 deletion
region). This is consistent with findings suggesting a role for multiple hits in
ASD<sup><xref ref-type="bibr" rid="R83">83</xref>,<xref ref-type="bibr" rid="R84">84</xref></sup>. Among the genes with recurrent mutation and
CNV intersection, <italic>MAPK3</italic> is particularly interesting with respect to
the chromosome 16p11.2 microduplication. Several functional studies on 16p11.2
deletion and duplication mice as well as <italic>Drosophila</italic> models have
suggested that <italic>MAPK3</italic> is a key regulator of the syndrome: being
downstream of other ASD target genes; involved in axon targeting and regulation of
cortical cytoarchitecture; and being the most topologically important gene in the
region by PPIs<sup><xref ref-type="bibr" rid="R85">85</xref>-<xref ref-type="bibr" rid="R87">87</xref></sup>. Our analysis builds on these studies by
providing evidence of recurrent missense mutation enrichment in human NDDs.</p>
<p id="P29">Finally, it is interesting that the 253 genes we highlight in this
meta-analysis demonstrate a pan-neuronal expression pattern with the majority of
genes being expressed in all GABAergic (inhibitory) and glutamatergic (excitatory)
neuron types (<xref ref-type="fig" rid="F3">Figure 3</xref>), suggesting these genes
have the potential to alter many paths in the adult cortical circuit. While the
majority of genes are broadly expressed across neuronal cell types, a subset
demonstrates evidence of specific expression. More specifically, we observed
enrichment for genes specifically expressed in the D1+ (19 genes) and D2+ (18 genes)
medium spiny neurons of the striatum (13 genes are shared in the D1+ and D2+ lists)
in mouse brain (<xref ref-type="supplementary-material" rid="SD1">Supplementary
Figure 2A</xref>). Previously, Dougherty and colleagues highlighted this
particular brain region based on a survey of genes reported as autism candidate risk
genes<sup><xref ref-type="bibr" rid="R48">48</xref></sup>. Using a CSEA, we
now extend this observation to NDD genes enriched for recurrent DNM. Remarkably, a
similar enrichment was recently reported in autistic individuals with multiple DNMs
in coding and putative noncoding regulatory DNA<sup><xref ref-type="bibr" rid="R84">84</xref></sup>. We also observe a similar signature for genes where
nominal significance has been observed for clustered DNMs. While many of the genes
enriched for D1+ and D2+ expression are not exclusive to the striatum and are more
broadly expressed (as demonstrated by the enrichment signal at the lowest
specificity threshold), the striatum has been implicated in ID and autism pathology
by numerous studies<sup><xref ref-type="bibr" rid="R88">88</xref>-<xref ref-type="bibr" rid="R97">97</xref></sup>. The striatum is particularly compelling as
it has been linked to repetitive behaviors<sup><xref ref-type="bibr" rid="R88">88</xref></sup> core to the autism phenotype and also to genes known to be
involved in DD, including <italic>CHD8</italic>, <italic>SHANK3</italic>,
<italic>FOXP2</italic>, and <italic>KCNA4</italic><sup><xref ref-type="bibr" rid="R89">89</xref>,<xref ref-type="bibr" rid="R90">90</xref>,<xref ref-type="bibr" rid="R93">93</xref>,<xref ref-type="bibr" rid="R96">96</xref>,<xref ref-type="bibr" rid="R97">97</xref></sup>. While the
striatum is most strongly linked to autism core phenotypes, our observation of
enrichment in a more general DD cohort suggests that, while the general bias of
cortex genes to ID and striatum genes to ASD<sup><xref ref-type="bibr" rid="R92">92</xref></sup> still holds, the diverse expression patterns of genes
across the brain at complex developmental time points may have substantial
functional overlap among subtypes of NDDs that will require deep phenotyping and
imaging to tease apart.</p>
<p id="P30">In conclusion, the 253 genes that show evidence for recurrent DNM represent
a starting point for further functional and phenotypic investigations. Of these
genes, 124 reach a strict GWAS threshold of significance strongly arguing that DNM
in these genes contributes significantly to disease. Overall, the genes we highlight
demonstrate strong conservation, refine pathogenic CNVs, define distinct functional
pathways, and support the role of striatal networks in the pathogenicity of both ASD
and ID/DD. Strikingly, the majority of the genes identified in this study present
with DNMs in both ASD and ID/DD. While we expect a degree of diagnostic
overlap<sup><xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22">22</xref></sup>, our results support a common genetic
etiology among broad neurodevelopmental phenotypes. These genes are candidates for a
genotype-first paradigm<sup><xref ref-type="bibr" rid="R98">98</xref></sup>, where
downstream follow-up of patients with the same <italic>de novo</italic> disrupted
gene is likely to provide additional insight into unique phenotypic features
associated with these different genetic subtypes<sup><xref ref-type="bibr" rid="R99">99</xref></sup> and additional support for their role in NDD.</p>
</sec>
<sec id="S9">
<title>METHODS</title>
<sec id="S10">
<title>Data set:</title>
<p id="P31">We analyzed <italic>de novo</italic> single-nucleotide and indel
variants from whole-exome sequencing (WES) data generated for 10,927 cases with
neurodevelopmental diagnoses of ASD or ID/DD compiled in the denovo-db v.1.5
release<sup><xref ref-type="bibr" rid="R20">20</xref></sup> (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>).
The subset of denovo-db v.1.5 cohorts used was specifically chosen to avoid
potential sample overlap as described in Geisheker et al.<sup><xref ref-type="bibr" rid="R14">14</xref></sup> and in the release documentation for
denovo-db v.1.5 (see <xref ref-type="sec" rid="S18">URLs</xref>). Briefly, we
first assumed minimal overlap between studies based in Europe and America and
studies with exclusion criteria, including participation in another study (e.g.,
SSC and the Autism Sequencing Consortium or ASC). This was supported by
screening for individuals with shared mutational sites and second
events<sup><xref ref-type="bibr" rid="R14">14</xref></sup>. We excluded
studies from The Autism Simplex Collection or TASC due to known sample overlaps;
additionally, we utilized only the more recent MSSNG data set<sup><xref ref-type="bibr" rid="R35">35</xref></sup> to avoid redundant
annotations. All variants were annotated to RefSeq transcripts using SnpEff and
collapsing to the most severe variant across isoforms. Variants were further
binned into LGD (stop loss/gain, splice, and frameshift), missense, or
synonymous categories for analysis. While these data are derived from a diverse
set of WES platforms with differing sensitivities, our DNM-based analysis
assumed samples to have perfect sensitivity. The combined set of 12,172 DNMs
includes 2,357 LGD and 9,815 missense mutations, representing the largest such
analysis to date. Each source study reports validated sites or validation rates
ranging from 88.2% to 100% (with the exception of the DDD study, which opted for
a high sensitivity approach) (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>). Among these events, 1,106 LGD and 2,594
missense DNMs were validated/confirmed in the original studies while the
remainder have unknown validation status (invalidated sites are not included in
this analysis). CNV region data was obtained from a previous study of 29,085
children with developmental disorders and 19,584 population controls<sup><xref ref-type="bibr" rid="R18">18</xref></sup> as well as a curated list of
genomic disorders maintained by DECIPHER (v.9.18) (see <xref ref-type="sec" rid="S18">URLs</xref>).</p>
</sec>
<sec id="S11">
<title>Statistics:</title>
<p id="P32">All standard statistical tests not reported by a described application
(see relevant Methods) were performed using the R statistical language (v3.2.4),
and non-parametric tests were used wherever possible. Wilcoxon rank-sum tests
were used for distribution comparisons, with the exception of the Tukey Honest
Significant Difference test for RVIS testing across all categories, and t-test
for IQ comparisons. Fisher’s exact test was used for all count
comparisons. Likelihood ratio tests for goodness of fit were performed using one
million multinomial sampling simulations. Multiple testing correction was
applied where appropriate using either the Benjamini-Hochberg FDR or Bonferroni
FWER as described in the relevant sections.</p>
</sec>
<sec id="S12">
<title>Recurrent variant analysis:</title>
<p id="P33">Enrichment of <italic>de novo</italic> LGD and missense variation per
gene was calculated using two statistical models. The CH model as previously
described<sup><xref ref-type="bibr" rid="R11">11</xref></sup> was run
using the default setting and assuming a baseline rate of 1.8 <italic>de
novo</italic> variants per individual (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>). We note
that ID/DD cohorts tend to have higher DNM rates than ASD cohorts, potentially
relating to a combination of both technical (chosen sensitivity, platform
differences) and biological biases, with the DDD cohort<sup><xref ref-type="bibr" rid="R9">9</xref></sup> demonstrating the highest DNM rate among
large cohorts<sup><xref ref-type="bibr" rid="R24">24</xref></sup>. We anticipate
that false positives would be randomly distributed and not enriched within
specific genes. Observed coding DNM (LGD or missense) rates in the exome studies
range from 0.87 to 1.36 among the large cohorts (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>). While these
variances in DNM rate likely influence our results, all rates are below the 1.8
DNM per individual rate used in the CH model; thus, overall our statistics will
be conservative. In addition, we ran a recently published modified
version<sup><xref ref-type="bibr" rid="R40">40</xref></sup> that
separately tests for enrichment of variants with CADD v.1.3 scores<sup><xref ref-type="bibr" rid="R39">39</xref></sup> of 30 and higher, which are
predicted to be the most damaging of missense variation. Similarly,
denovolyzeR<sup><xref ref-type="bibr" rid="R12">12</xref></sup> (R
package version v0.2.0) was run using default settings. Each test (LGD,
missense, MIS30) was individually adjusted to a q-value by the
Benjamini-Hochberg procedure based on the number of genes in the model (exome
wide) and genes with q-value &lt; 0.05 and a DNM count of two or more were
considered for the union set. Wherever necessary, gene symbols were adjusted to
match those used in the individual models (CH model, denovolyzeR, CSEA). In
cases where no model was generated for a gene of interest, “no
model” is indicated in the significance column of <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>. Each
analysis was corrected genome-wide for the number of genes present in the
corresponding models (18,946 for CH model and 19,618 for denovolyzeR).</p>
<p id="P34">While the q-value threshold should control the FDR within a single list,
the combination of two models has the potential to increase the upper bound of
the FDR for both the union and intersection. Although we assume that the FDR
should remain at 5% on average, the upper limits to the merged FDRs can be
defined as follows: <disp-formula id="FD1"><mml:math display="block" id="M1" overflow="scroll"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mo>∪</mml:mo><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>∪</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>B</mml:mi><mml:mo>\</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mi>A</mml:mi><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>\</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>B</mml:mi><mml:mo>\</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>∪</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>B</mml:mi><mml:mo>\</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:msub><mml:mspace width="0.25em"></mml:mspace><mml:mi>B</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mi>A</mml:mi><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>\</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:msub><mml:mspace width="0.25em"></mml:mspace><mml:mi>A</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mi>O</mml:mi><mml:mi>R</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>B</mml:mi><mml:mo>\</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>\</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>\</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>∪</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>\</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mspace width="0.25em"></mml:mspace><mml:mi>A</mml:mi><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>B</mml:mi><mml:mo>\</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mi>O</mml:mi><mml:mi>R</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>\</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≤</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>B</mml:mi><mml:mo>\</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mo>∩</mml:mo><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mspace width="0.25em"></mml:mspace><mml:mo>≤</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>*</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>∩</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mo>≤</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mi>A</mml:mi><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>∩</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>A</mml:mi></mml:msub><mml:mo>*</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo>*</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>∩</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mo>≤</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>A</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:mspace width="0.25em"></mml:mspace><mml:mi>A</mml:mi><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mspace width="0.25em"></mml:mspace><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mo>∩</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo>*</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>B</mml:mi><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
<p id="P35">Application of these upper bounds estimates the maximal error rates in
the unions as LGD FDR &lt; 8.59%; Missense FDR &lt; 7.56%. As MIS30 is
only examined by one model, its estimated FDR remains at 5%. Similarly, we
estimate the maximal error rates in the intersections as LGD FDR &lt; 5.7%;
Missense FDR &lt; 6.75%. We wish to stress that we anticipate these to be
upper bounds. In addition to the described treatment, to increase the stringency
of our union set, we excluded any gene with a single DNM from further
consideration. As a result, we discarded q-values for 1,183 LGD, 4,246 missense,
and 1,083 MIS30 genes of which 113 reach corrected significance but are
primarily small genes. This represents elimination of ~5-15% of the genes
further reducing the overall FDR. Despite their likely enrichment for false
positives, 11 of 113 single-hit genes have been previously implicated in an NDD
(<xref ref-type="supplementary-material" rid="SD3">Supplementary Table
2</xref>) and are thus potentially of interest for future studies with
additional samples.</p>
</sec>
<sec id="S13">
<title>Identification of novel genes:</title>
<p id="P36">To address novelty, we considered statistically significant genes as
defined by five recent publications involving large-scale exome, whole-genome,
or targeted sequencing (DeRubeis et al.<sup><xref ref-type="bibr" rid="R26">26</xref></sup>, Sanders et al.<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, an in-press revised version of Stessman et
al.<sup><xref ref-type="bibr" rid="R10">10</xref></sup>, Yuen et
al.<sup><xref ref-type="bibr" rid="R35">35</xref></sup>, DDD
2017<sup><xref ref-type="bibr" rid="R24">24</xref></sup>) and three
well-curated databases (OMIM, SFARI Gene, and ID Gene Database Project, see
<xref ref-type="sec" rid="S18">URLs</xref>; all database queries made on
02/19/2018). We undertook the following approach to ‘novelty’ when
comparing these data sets to our list of 253 significant genes. Any gene listed
as significant (regardless of thresholds or alternative methods of significance
(CNV integration, private variation, inherited variation)) in any of these data
sets was not considered ‘novel’ in our data set. Additionally, we
considered SFARI genes of any score category as known. For the 80/253 genes not
“known” by this initial screen, we followed up with literature
searches for evidence of any link to case reports or human studies of ID,
autism, or mental retardation, or DD. For 49/80 genes, no evidence was found
through the PubMed search; this represents our most conservative set of
‘novel’ genes (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 3</xref>). While this pool is the most likely to
contain false positive findings, 10 of these 49 genes were also significant
under an FWER correction (<italic>SMARCD1</italic>, <italic>SNX5</italic>,
<italic>TNPO2</italic>, <italic>ADAP1</italic>, <italic>CAPN15</italic>,
<italic>CHD3</italic>, <italic>TMEM178A</italic>, <italic>AGO4</italic>,
<italic>SNAPC5</italic>, and <italic>ANP32A</italic>). Clinical evidence,
even single case reports, adds credence to our gene list as high-confidence
candidates for NDD pathology.</p>
</sec>
<sec id="S14">
<title>Network analysis:</title>
<p id="P37">Identification of clustered gene modules was performed using the MAGI
(<underline>m</underline>erging <underline>a</underline>ffected
<underline>g</underline>enes into <underline>i</underline>ntegrated
networks)<sup><xref ref-type="bibr" rid="R43">43</xref></sup> enrichment
tool with default settings, followed by visualization incorporating
co-expression and physical interaction data from geneMANIA<sup><xref ref-type="bibr" rid="R100">100</xref></sup>. Significance for MAGI modules was
performed by permuting DNM across genes according to their mutation rates in the
CH model 100 times and enumerating the number of random modules with scores
greater than or equal to the module of interest.</p>
</sec>
<sec id="S15">
<title>Expression analysis in mouse:</title>
<p id="P38">Functional enrichment was examined using the CSEA and TSEA
tools<sup><xref ref-type="bibr" rid="R48">48</xref></sup>.
CSEA<sup><xref ref-type="bibr" rid="R48">48</xref></sup> was
additionally applied to candidate genes using single-cell transcriptomic
profiling data from mouse cortex and hippocampus<sup><xref ref-type="bibr" rid="R101">101</xref></sup> using custom R scripts. Raw mRNA count
data was downloaded from (see <xref ref-type="sec" rid="S18">URLs</xref>, and
only genes with at least 25 total molecules and at least 1 molecule in
≥100 cells were retained. Molecule counts were then incremented by a
pseudo-count of 0.125 and RPKM-normalized. RPKMs were averaged over each of the
47 cell subclasses identified by the authors using the BackSPIN clustering
algorithm. Significantly enriched transcripts in each subclass were identified
using the pSI package<sup><xref ref-type="bibr" rid="R47">47</xref></sup> with a
minimum expression value of 3 RPKM and default settings otherwise.</p>
</sec>
<sec id="S16">
<title>Expression analysis in humans:</title>
<p id="P39">15,928 single nuclei were isolated from the middle temporal gyrus of
adult post-mortem brains of three human donors and profiled with RNA-sequencing.
Raw read (fastq) files were aligned to the GRCh38 human genome sequence (Genome
Reference Consortium, 2011) with the RefSeq transcriptome version GRCh38.p2
(current as of 4/13/2015). For alignment, Illumina sequencing adapters were
clipped from the reads using the fastqMCF program (ea-utils, see <xref ref-type="sec" rid="S18">URLs</xref>). After clipping, the paired-end reads were
mapped using Spliced Transcripts Alignment to a Reference (STAR)<sup><xref ref-type="bibr" rid="R102">102</xref></sup> with default settings.
Unsupervised clustering identified 71 distinct transcriptomic clusters,
including 41 GABAergic (inhibitory) neuronal, 24 glutamatergic (excitatory)
neuronal, and 6 non-neuronal cell types (unpublished). For each gene, the
expression pattern was characterized as the number of cell types with
appreciable expression (median counts per million [CPM] &gt; 1) in three
broad classes: inhibitory and excitatory neurons and glia. Heatmaps were
constructed of log-normalized expression (log<sub>2</sub>CPM + 1) of NDD risk
genes and control genes across cell types. The number of inhibitory and
excitatory neuronal and glial types that expressed NDD risk genes and control
genes were quantified and visualized as empirical cumulative distributions.
Distributions were compared with two-sided Wilcoxon rank-sum tests for each
broad class of cell types, and p-values were Bonferroni corrected for multiple
testing. A cell type specificity or marker score (beta) was defined for all
genes to measure how binary expression was among clusters, independent of the
number of clusters labeled. First, the proportion (x) of samples in each cluster
that expressed a gene above background level (CPM &gt; 1) was calculated.
Then, scores were defined as the squared differences in proportions between all
pairs (i,j) of n clusters normalized by the sum of absolute differences plus a
small constant (ε) to avoid division by zero. Scores ranged from 0 to 1,
and a perfectly binary marker had a score equal to 1.</p>
<disp-formula id="FD2">
<mml:math display="block" id="M2" overflow="scroll">
<mml:mrow>
<mml:mi>β</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo></mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msubsup>
<mml:mstyle displaystyle="true" mathsize="140%">
<mml:mo>∑</mml:mo>
</mml:mstyle>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>n</mml:mi>
</mml:msubsup>
<mml:msubsup>
<mml:mstyle displaystyle="true" mathsize="140%">
<mml:mo>∑</mml:mo>
</mml:mstyle>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>n</mml:mi>
</mml:msubsup>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>x</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>x</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
<mml:mrow>
<mml:mo></mml:mo>
<mml:msubsup>
<mml:mstyle displaystyle="true" mathsize="140%">
<mml:mo>∑</mml:mo>
</mml:mstyle>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>n</mml:mi>
</mml:msubsup>
<mml:msubsup>
<mml:mstyle displaystyle="true" mathsize="140%">
<mml:mo>∑</mml:mo>
</mml:mstyle>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>n</mml:mi>
</mml:msubsup>
<mml:mrow>
<mml:mo>|</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>x</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>x</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo>|</mml:mo>
</mml:mrow>
<mml:mo>+</mml:mo>
<mml:mo></mml:mo>
<mml:mi>ε</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
<p id="P40">Shapiro-Wilk tests rejected (p &lt; 0.05) the null hypothesis that
distributions were normally distributed of cell type counts for each broad
class, maximum average expression, and marker scores. Therefore, distributions
were compared with two-sided Wilcoxon rank-sum tests, and p-values were
Bonferroni corrected for multiple testing.</p>
</sec>
<sec id="S17">
<title>Projected rates of gene discovery:</title>
<p id="P41">Prediction of future LGD and missense variation discovery rates was
determined by sampling (with replacement) populations of 100 to 10,900 cases
10,000 times each and calculating DNM statistics using the CH model. The number
of genes with two or more mutations and a q-value below 0.05 were then
enumerated for each simulation and linear as well as logistic growth models were
fit to each curve with the best model being chosen by BIC. Model fits and
confidence bounds were performed using the base stats and propagate (see <xref ref-type="sec" rid="S18">URLs</xref>) packages in the R statistical
language.</p>
</sec>
</sec>
<sec id="S18">
<title>URLS</title>
<p id="P48">denovo-db, <ext-link ext-link-type="uri" xlink:href="http://denovo-db.gs.washington.edu/">http://denovo-db.gs.washington.edu/</ext-link>; denovo-db v.1.5 documentation,
<ext-link ext-link-type="uri" xlink:href="http://denovo-db.gs.washington.edu/denovo-db.v.1.5.pdf">http://denovo-db.gs.washington.edu/denovo-db.v.1.5.pdf</ext-link>; DECIPHER,
<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk</ext-link>; Online Mendelian
Inheritance in Man (OMIM), <ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">https://www.omim.org</ext-link>; SFARI Gene, <ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/">https://gene.sfari.org/</ext-link>; ID Gene Database Project, <ext-link ext-link-type="uri" xlink:href="http://gfuncpathdb.ucdenver.edu/iddrc/iddrc/home.php">http://gfuncpathdb.ucdenver.edu/iddrc/iddrc/home.php</ext-link>; Linnarsson Lab
Single-cell analysis of mouse cortex,<ext-link ext-link-type="uri" xlink:href="http://linnarssonlab.org/cortex">http://linnarssonlab.org/cortex</ext-link>; ea-utils fastqMCF program,
<ext-link ext-link-type="uri" xlink:href="https://expressionanalysis.github.io/ea-utils/">https://expressionanalysis.github.io/ea-utils/</ext-link>; R package
‘propagate’, <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=propagate">https://CRAN.R-project.org/package=propagate</ext-link>; DECIPHER Syndrome
Overview <ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/disorders#syndromes/overview">https://decipher.sanger.ac.uk/disorders#syndromes/overview</ext-link>; Human
MTG single nucleus RNA-seq data, <ext-link ext-link-type="uri" xlink:href="http://celltypes.brain-map.org/download">http://celltypes.brain-map.org/download</ext-link></p>
</sec>
<sec id="SM1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>1</label>
<media id="d36e2711" orientation="portrait" position="anchor" xlink:href="NIHMS1510455-supplement-1.doc" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>2</label>
<media id="d36e2715" orientation="portrait" position="anchor" xlink:href="NIHMS1510455-supplement-2.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>Supplementary Tables S1-S8</label>
<media id="d36e2719" orientation="portrait" position="anchor" xlink:href="NIHMS1510455-supplement-Supplementary_Tables_S1-S8.xlsx" xlink:type="simple"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S19">
<title>ACKNOWLEDGEMENTS</title>
<p id="P42">We wish to thank Tychele Turner and Jay Shendure for helpful discussion and
Tonia Brown for edits. This research was supported, in part, by the following: the
Simons Foundation Autism Research Initiative (SFARI 303241) and US National
Institutes of Health (NIH R01MH101221) to E.E.E. The J.D.D. lab is supported by a
NARSAD Independent Investigator Award from the Brain and Behavior Research
Foundation, as well as NIH (5R01MH107515-03). We are grateful to all of the families
at the participating Simons Simplex Collection (SSC) sites, as well as the principal
investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D.
Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C.
Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J.
Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, E.
Wijsman). E.E.E. is an investigator of the Howard Hughes Medical Institute.</p>
</ack>
<fn-group>
<fn id="FN2">
<p id="P43">DATA AVAILIBILITY STATEMENT</p>
<p id="P44">All variant data in this study is available to download from denovo-db
v.1.5 (see <xref ref-type="sec" rid="S18">URLs</xref>). Human MTG single-nucleus
RNA-seq data and clusters can be downloaded from the Allen Institute for Brain
Science web site: <ext-link ext-link-type="uri" xlink:href="http://celltypes.brain-map.org/download">http://celltypes.brain-map.org/download</ext-link>.</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p id="P45">COMPETING FINANCIAL INTERESTS</p>
<p id="P46">E.E.E. is on the scientific advisory board (SAB) of DNAnexus, Inc.</p>
</fn>
<fn id="FN4">
<p id="P47"><bold>Reporting summary:</bold> Further information on experimental
design is available in the Nature Research Reporting Summary linked to this
article.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<label>1.</label>
<mixed-citation publication-type="journal"><name><surname>Sebat</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>Strong association of de novo copy number mutations with
autism</article-title>. <source/>Science
<volume>316</volume>, <fpage>445</fpage>–<lpage>9</lpage>
(<year>2007</year>).<pub-id pub-id-type="pmid">17363630</pub-id></mixed-citation>
</ref>
<ref id="R2">
<label>2.</label>
<mixed-citation publication-type="journal"><name><surname>Sharp</surname><given-names>AJ</given-names></name>
<etal></etal>
<article-title>Segmental duplications and copy-number variation in the human
genome</article-title>. <source/>Am J Hum Genet
<volume>77</volume>, <fpage>78</fpage>–<lpage>88</lpage>
(<year>2005</year>).<pub-id pub-id-type="pmid">15918152</pub-id></mixed-citation>
</ref>
<ref id="R3">
<label>3.</label>
<mixed-citation publication-type="journal"><name><surname>Tuzun</surname><given-names>E</given-names></name>
<etal></etal>
<article-title>Fine-scale structural variation of the human
genome</article-title>. <source/>Nat Genet
<volume>37</volume>, <fpage>727</fpage>–<lpage>32</lpage>
(<year>2005</year>).<pub-id pub-id-type="pmid">15895083</pub-id></mixed-citation>
</ref>
<ref id="R4">
<label>4.</label>
<mixed-citation publication-type="journal"><name><surname>de Vries</surname><given-names>BB</given-names></name>
<etal></etal>
<article-title>Diagnostic genome profiling in mental
retardation</article-title>. <source/>Am J Hum Genet
<volume>77</volume>, <fpage>606</fpage>–<lpage>16</lpage>
(<year>2005</year>).<pub-id pub-id-type="pmid">16175506</pub-id></mixed-citation>
</ref>
<ref id="R5">
<label>5.</label>
<mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>JA</given-names></name>, <name><surname>Yavor</surname><given-names>AM</given-names></name>, <name><surname>Massa</surname><given-names>HF</given-names></name>, <name><surname>Trask</surname><given-names>BJ</given-names></name> &amp; <name><surname>Eichler</surname><given-names>EE</given-names></name>
<article-title>Segmental duplications: organization and impact within the
current human genome project assembly</article-title>. <source/>Genome
Res
<volume>11</volume>, <fpage>1005</fpage>–<lpage>17</lpage>
(<year>2001</year>).<pub-id pub-id-type="pmid">11381028</pub-id></mixed-citation>
</ref>
<ref id="R6">
<label>6.</label>
<mixed-citation publication-type="journal"><name><surname>de Vries</surname><given-names>BB</given-names></name>
<etal></etal>
<article-title>Clinical studies on submicroscopic subtelomeric rearrangements: a
checklist</article-title>. <source/>J Med Genet
<volume>38</volume>, <fpage>145</fpage>–<lpage>50</lpage>
(<year>2001</year>).<pub-id pub-id-type="pmid">11238680</pub-id></mixed-citation>
</ref>
<ref id="R7">
<label>7.</label>
<mixed-citation publication-type="journal"><name><surname>Firth</surname><given-names>HV</given-names></name> &amp; <name><surname>Wright</surname><given-names>CF</given-names></name>
<article-title>The Deciphering Developmental Disorders (DDD)
study</article-title>. <source/>Dev Med Child Neurol
<volume>53</volume>, <fpage>702</fpage>–<lpage>3</lpage>
(<year>2011</year>).<pub-id pub-id-type="pmid">21679367</pub-id></mixed-citation>
</ref>
<ref id="R8">
<label>8.</label>
<mixed-citation publication-type="journal"><name><surname>O’Roak</surname><given-names>BJ</given-names></name>
<etal></etal>
<article-title>Exome sequencing in sporadic autism spectrum disorders identifies
severe de novo mutations</article-title>. <source/>Nat Genet
<volume>43</volume>, <fpage>585</fpage>–<lpage>9</lpage>
(<year>2011</year>).<pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
</ref>
<ref id="R9">
<label>9.</label>
<mixed-citation publication-type="journal"><article-title>Large-scale discovery of
novel genetic causes of developmental disorders</article-title>.
<source/>Nature
<volume>519</volume>, <fpage>223</fpage>–<lpage>8</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">25533962</pub-id></mixed-citation>
</ref>
<ref id="R10">
<label>10.</label>
<mixed-citation publication-type="journal"><name><surname>Stessman</surname><given-names>HA</given-names></name>
<etal></etal>
<article-title>Targeted sequencing identifies 91 neurodevelopmental-disorder
risk genes with autism and developmental-disability biases</article-title>.
<source/>Nat Genet
<volume>49</volume>, <fpage>515</fpage>–<lpage>526</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28191889</pub-id></mixed-citation>
</ref>
<ref id="R11">
<label>11.</label>
<mixed-citation publication-type="journal"><name><surname>O’Roak</surname><given-names>BJ</given-names></name>
<etal></etal>
<article-title>Multiplex targeted sequencing identifies recurrently mutated
genes in autism spectrum disorders</article-title>. <source/>Science
<volume>338</volume>, <fpage>1619</fpage>–<lpage>22</lpage>
(<year>2012</year>).<pub-id pub-id-type="pmid">23160955</pub-id></mixed-citation>
</ref>
<ref id="R12">
<label>12.</label>
<mixed-citation publication-type="journal"><name><surname>Samocha</surname><given-names>KE</given-names></name>
<etal></etal>
<article-title>A framework for the interpretation of de novo mutation in human
disease</article-title>. <source/>Nat Genet
<volume>46</volume>, <fpage>944</fpage>–<lpage>50</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">25086666</pub-id></mixed-citation>
</ref>
<ref id="R13">
<label>13.</label>
<mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>TN</given-names></name>
<etal></etal>
<article-title>Proteins linked to autosomal dominant and autosomal recessive
disorders harbor characteristic rare missense mutation distribution
patterns</article-title>. <source/>Hum Mol Genet
<volume>24</volume>, <fpage>5995</fpage>–<lpage>6002</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">26246501</pub-id></mixed-citation>
</ref>
<ref id="R14">
<label>14.</label>
<mixed-citation publication-type="journal"><name><surname>Geisheker</surname><given-names>MR</given-names></name>
<etal></etal>
<article-title>Hotspots of missense mutation identify neurodevelopmental
disorder genes and functional domains</article-title>. <source/>Nat
Neurosci
<volume>20</volume>, <fpage>1043</fpage>–<lpage>1051</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28628100</pub-id></mixed-citation>
</ref>
<ref id="R15">
<label>15.</label>
<mixed-citation publication-type="journal"><name><surname>Lelieveld</surname><given-names>SH</given-names></name>
<etal></etal>
<article-title>Spatial Clustering of de Novo Missense Mutations Identifies
Candidate Neurodevelopmental Disorder-Associated Genes</article-title>.
<source/>Am J Hum Genet
<volume>101</volume>, <fpage>478</fpage>–<lpage>484</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28867141</pub-id></mixed-citation>
</ref>
<ref id="R16">
<label>16.</label>
<mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>GM</given-names></name>
<etal></etal>
<article-title>A copy number variation morbidity map of developmental
delay</article-title>. <source/>Nat Genet
<volume>43</volume>, <fpage>838</fpage>–<lpage>46</lpage>
(<year>2011</year>).<pub-id pub-id-type="pmid">21841781</pub-id></mixed-citation>
</ref>
<ref id="R17">
<label>17.</label>
<mixed-citation publication-type="journal"><name><surname>Kaminsky</surname><given-names>EB</given-names></name>
<etal></etal>
<article-title>An evidence-based approach to establish the functional and
clinical significance of copy number variants in intellectual and
developmental disabilities</article-title>. <source/>Genet Med
<volume>13</volume>, <fpage>777</fpage>–<lpage>84</lpage>
(<year>2011</year>).<pub-id pub-id-type="pmid">21844811</pub-id></mixed-citation>
</ref>
<ref id="R18">
<label>18.</label>
<mixed-citation publication-type="journal"><name><surname>Coe</surname><given-names>BP</given-names></name>
<etal></etal>
<article-title>Refining analyses of copy number variation identifies specific
genes associated with developmental delay</article-title>. <source/>Nat
Genet
<volume>46</volume>, <fpage>1063</fpage>–<lpage>71</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">25217958</pub-id></mixed-citation>
</ref>
<ref id="R19">
<label>19.</label>
<mixed-citation publication-type="journal"><name><surname>Sanders</surname><given-names>SJ</given-names></name>
<etal></etal>
<article-title>Insights into Autism Spectrum Disorder Genomic Architecture and
Biology from 71 Risk Loci</article-title>. <source/>Neuron
<volume>87</volume>, <fpage>1215</fpage>–<lpage>33</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">26402605</pub-id></mixed-citation>
</ref>
<ref id="R20">
<label>20.</label>
<mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>TN</given-names></name>
<etal></etal>
<article-title>denovo-db: a compendium of human de novo
variants</article-title>. <source/>Nucleic Acids Res
<volume>45</volume>, <fpage>D804</fpage>–<lpage>D811</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">27907889</pub-id></mixed-citation>
</ref>
<ref id="R21">
<label>21.</label>
<mixed-citation publication-type="journal"><name><surname>Matson</surname><given-names>JL</given-names></name> &amp; <name><surname>Shoemaker</surname><given-names>M</given-names></name>
<article-title>Intellectual disability and its relationship to autism spectrum
disorders</article-title>. <source/>Res Dev Disabil
<volume>30</volume>, <fpage>1107</fpage>–<lpage>14</lpage>
(<year>2009</year>).<pub-id pub-id-type="pmid">19604668</pub-id></mixed-citation>
</ref>
<ref id="R22">
<label>22.</label>
<mixed-citation publication-type="journal"><article-title>Diagnostic and statistical
manual of mental disorders. 5</article-title>. <source/>American Psychiatric
Association (<year>2013</year>).</mixed-citation>
</ref>
<ref id="R23">
<label>23.</label>
<mixed-citation publication-type="journal"><name><surname>Iossifov</surname><given-names>I</given-names></name>
<etal></etal>
<article-title>The contribution of de novo coding mutations to autism spectrum
disorder</article-title>. <source/>Nature
<volume>515</volume>, <fpage>216</fpage>–<lpage>21</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="R24">
<label>24.</label>
<mixed-citation publication-type="journal"><article-title>Prevalence and
architecture of de novo mutations in developmental
disorders</article-title>. <source/>Nature
<volume>542</volume>, <fpage>433</fpage>–<lpage>438</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28135719</pub-id></mixed-citation>
</ref>
<ref id="R25">
<label>25.</label>
<mixed-citation publication-type="journal"><name><surname>de Ligt</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>Diagnostic exome sequencing in persons with severe intellectual
disability</article-title>. <source/>N Engl J Med
<volume>367</volume>, <fpage>1921</fpage>–<lpage>9</lpage>
(<year>2012</year>).<pub-id pub-id-type="pmid">23033978</pub-id></mixed-citation>
</ref>
<ref id="R26">
<label>26.</label>
<mixed-citation publication-type="journal"><name><surname>De Rubeis</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in
autism</article-title>. <source/>Nature
<volume>515</volume>, <fpage>209</fpage>–<lpage>15</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="R27">
<label>27.</label>
<mixed-citation publication-type="journal"><name><surname>Halvardson</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>Mutations in HECW2 are associated with intellectual disability
and epilepsy</article-title>. <source/>J Med Genet
<volume>53</volume>, <fpage>697</fpage>–<lpage>704</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27334371</pub-id></mixed-citation>
</ref>
<ref id="R28">
<label>28.</label>
<mixed-citation publication-type="journal"><name><surname>Hashimoto</surname><given-names>R</given-names></name>
<etal></etal>
<article-title>Whole-exome sequencing and neurite outgrowth analysis in autism
spectrum disorder</article-title>. <source/>J Hum Genet
<volume>61</volume>, <fpage>199</fpage>–<lpage>206</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">26582266</pub-id></mixed-citation>
</ref>
<ref id="R29">
<label>29.</label>
<mixed-citation publication-type="journal"><name><surname>Krumm</surname><given-names>N</given-names></name>
<etal></etal>
<article-title>Excess of rare, inherited truncating mutations in
autism</article-title>. <source/>Nat Genet
<volume>47</volume>, <fpage>582</fpage>–<lpage>8</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">25961944</pub-id></mixed-citation>
</ref>
<ref id="R30">
<label>30.</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>H</given-names></name>, <name><surname>Lin</surname><given-names>MC</given-names></name>, <name><surname>Kornblum</surname><given-names>HI</given-names></name>, <name><surname>Papazian</surname><given-names>DM</given-names></name> &amp; <name><surname>Nelson</surname><given-names>SF</given-names></name>
<article-title>Exome sequencing identifies de novo gain of function missense
mutation in KCND2 in identical twins with autism and seizures that slows
potassium channel inactivation</article-title>. <source/>Hum Mol
Genet
<volume>23</volume>, <fpage>3481</fpage>–<lpage>9</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">24501278</pub-id></mixed-citation>
</ref>
<ref id="R31">
<label>31.</label>
<mixed-citation publication-type="journal"><name><surname>Lelieveld</surname><given-names>SH</given-names></name>
<etal></etal>
<article-title>Meta-analysis of 2,104 trios provides support for 10 new genes
for intellectual disability</article-title>. <source/>Nat Neurosci
<volume>19</volume>, <fpage>1194</fpage>–<lpage>6</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27479843</pub-id></mixed-citation>
</ref>
<ref id="R32">
<label>32.</label>
<mixed-citation publication-type="journal"><name><surname>Michaelson</surname><given-names>JJ</given-names></name>
<etal></etal>
<article-title>Whole-genome sequencing in autism identifies hot spots for de
novo germline mutation</article-title>. <source/>Cell
<volume>151</volume>, <fpage>1431</fpage>–<lpage>42</lpage>
(<year>2012</year>).<pub-id pub-id-type="pmid">23260136</pub-id></mixed-citation>
</ref>
<ref id="R33">
<label>33.</label>
<mixed-citation publication-type="journal"><name><surname>Moreno-Ramos</surname><given-names>OA</given-names></name>, <name><surname>Olivares</surname><given-names>AM</given-names></name>, <name><surname>Haider</surname><given-names>NB</given-names></name>, <name><surname>de Autismo</surname><given-names>LC</given-names></name> &amp; <name><surname>Lattig</surname><given-names>MC</given-names></name>
<article-title>Whole-Exome Sequencing in a South American Cohort Links ALDH1A3,
FOXN1 and Retinoic Acid Regulation Pathways to Autism Spectrum
Disorders</article-title>. <source/>PLoS One
<volume>10</volume>, <fpage>e0135927</fpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">26352270</pub-id></mixed-citation>
</ref>
<ref id="R34">
<label>34.</label>
<mixed-citation publication-type="journal"><name><surname>Rauch</surname><given-names>A</given-names></name>
<etal></etal>
<article-title>Range of genetic mutations associated with severe non-syndromic
sporadic intellectual disability: an exome sequencing study</article-title>.
<source/>Lancet
<volume>380</volume>, <fpage>1674</fpage>–<lpage>82</lpage>
(<year>2012</year>).<pub-id pub-id-type="pmid">23020937</pub-id></mixed-citation>
</ref>
<ref id="R35">
<label>35.</label>
<mixed-citation publication-type="journal"><name><surname>RK</surname><given-names>CY</given-names></name>
<etal></etal>
<article-title>Whole genome sequencing resource identifies 18 new candidate
genes for autism spectrum disorder</article-title>. <source/>Nat
Neurosci
<volume>20</volume>, <fpage>602</fpage>–<lpage>611</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28263302</pub-id></mixed-citation>
</ref>
<ref id="R36">
<label>36.</label>
<mixed-citation publication-type="journal"><name><surname>Tavassoli</surname><given-names>T</given-names></name>
<etal></etal>
<article-title>De novo SCN2A splice site mutation in a boy with Autism spectrum
disorder</article-title>. <source/>BMC Med Genet
<volume>15</volume>, <fpage>35</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24650168</pub-id></mixed-citation>
</ref>
<ref id="R37">
<label>37.</label>
<mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>TN</given-names></name>
<etal></etal>
<article-title>Genome Sequencing of Autism-Affected Families Reveals Disruption
of Putative Noncoding Regulatory DNA</article-title>. <source/>Am J Hum
Genet
<volume>98</volume>, <fpage>58</fpage>–<lpage>74</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">26749308</pub-id></mixed-citation>
</ref>
<ref id="R38">
<label>38.</label>
<mixed-citation publication-type="journal"><name><surname>Yuen</surname><given-names>RK</given-names></name>
<etal></etal>
<article-title>Genome-wide characteristics of de novo mutations in
autism</article-title>. <source/>NPJ Genom Med
<volume>1</volume>, <fpage>160271</fpage>–<lpage>1602710</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27525107</pub-id></mixed-citation>
</ref>
<ref id="R39">
<label>39.</label>
<mixed-citation publication-type="journal"><name><surname>Kircher</surname><given-names>M</given-names></name>
<etal></etal>
<article-title>A general framework for estimating the relative pathogenicity of
human genetic variants</article-title>. <source/>Nat Genet
<volume>46</volume>, <fpage>310</fpage>–<lpage>5</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
</ref>
<ref id="R40">
<label>40.</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>T</given-names></name>
<etal></etal>
<article-title>De novo genic mutations among a Chinese autism spectrum disorder
cohort</article-title>. <source/>Nat Commun
<volume>7</volume>, <fpage>13316</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27824329</pub-id></mixed-citation>
</ref>
<ref id="R41">
<label>41.</label>
<mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>
<etal></etal>
<article-title>Analysis of protein-coding genetic variation in 60,706
humans</article-title>. <source/>Nature
<volume>536</volume>, <fpage>285</fpage>–<lpage>91</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="R42">
<label>42.</label>
<mixed-citation publication-type="journal"><name><surname>Le Meur</surname><given-names>N</given-names></name>
<etal></etal>
<article-title>MEF2C haploinsufficiency caused by either microdeletion of the
5q14.3 region or mutation is responsible for severe mental retardation with
stereotypic movements, epilepsy and/or cerebral
malformations</article-title>. <source/>J Med Genet
<volume>47</volume>, <fpage>22</fpage>–<lpage>9</lpage>
(<year>2010</year>).<pub-id pub-id-type="pmid">19592390</pub-id></mixed-citation>
</ref>
<ref id="R43">
<label>43.</label>
<mixed-citation publication-type="journal"><name><surname>Hormozdiari</surname><given-names>F</given-names></name>, <name><surname>Penn</surname><given-names>O</given-names></name>, <name><surname>Borenstein</surname><given-names>E</given-names></name> &amp; <name><surname>Eichler</surname><given-names>EE</given-names></name>
<article-title>The discovery of integrated gene networks for autism and related
disorders</article-title>. <source/>Genome Res
<volume>25</volume>, <fpage>142</fpage>–<lpage>54</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">25378250</pub-id></mixed-citation>
</ref>
<ref id="R44">
<label>44.</label>
<mixed-citation publication-type="journal"><name><surname>Endele</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>Mutations in GRIN2A and GRIN2B encoding regulatory subunits of
NMDA receptors cause variable neurodevelopmental phenotypes</article-title>.
<source/>Nat Genet
<volume>42</volume>, <fpage>1021</fpage>–<lpage>6</lpage>
(<year>2010</year>).<pub-id pub-id-type="pmid">20890276</pub-id></mixed-citation>
</ref>
<ref id="R45">
<label>45.</label>
<mixed-citation publication-type="journal"><name><surname>Ching</surname><given-names>MS</given-names></name>
<etal></etal>
<article-title>Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of
developmental disorders</article-title>. <source/>Am J Med Genet B
Neuropsychiatr Genet
<volume>153B</volume>, <fpage>937</fpage>–<lpage>47</lpage>
(<year>2010</year>).<pub-id pub-id-type="pmid">20468056</pub-id></mixed-citation>
</ref>
<ref id="R46">
<label>46.</label>
<mixed-citation publication-type="journal"><name><surname>Stephenson</surname><given-names>JR</given-names></name>
<etal></etal>
<article-title>A Novel Human CAMK2A Mutation Disrupts Dendritic Morphology and
Synaptic Transmission, and Causes ASD-Related Behaviors</article-title>.
<source/>J Neurosci
<volume>37</volume>, <fpage>2216</fpage>–<lpage>2233</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28130356</pub-id></mixed-citation>
</ref>
<ref id="R47">
<label>47.</label>
<mixed-citation publication-type="journal"><name><surname>Dougherty</surname><given-names>JD</given-names></name>, <name><surname>Schmidt</surname><given-names>EF</given-names></name>, <name><surname>Nakajima</surname><given-names>M</given-names></name> &amp; <name><surname>Heintz</surname><given-names>N</given-names></name>
<article-title>Analytical approaches to RNA profiling data for the
identification of genes enriched in specific cells</article-title>.
<source/>Nucleic Acids Res
<volume>38</volume>, <fpage>4218</fpage>–<lpage>30</lpage>
(<year>2010</year>).<pub-id pub-id-type="pmid">20308160</pub-id></mixed-citation>
</ref>
<ref id="R48">
<label>48.</label>
<mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Wells</surname><given-names>AB</given-names></name>, <name><surname>O’Brien</surname><given-names>DR</given-names></name>, <name><surname>Nehorai</surname><given-names>A</given-names></name> &amp; <name><surname>Dougherty</surname><given-names>JD</given-names></name>
<article-title>Cell type-specific expression analysis to identify putative
cellular mechanisms for neurogenetic disorders</article-title>. <source/>J
Neurosci
<volume>34</volume>, <fpage>1420</fpage>–<lpage>31</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">24453331</pub-id></mixed-citation>
</ref>
<ref id="R49">
<label>49.</label>
<mixed-citation publication-type="journal"><name><surname>Deshpande</surname><given-names>A</given-names></name> &amp; <name><surname>Weiss</surname><given-names>LA</given-names></name>
<article-title>Recurrent reciprocal copy number variants: Roles and rules in
neurodevelopmental disorders</article-title>. <source/>Dev Neurobiol
<volume>78</volume>, <fpage>519</fpage>–<lpage>530</lpage>
(<year>2018</year>).<pub-id pub-id-type="pmid">29575775</pub-id></mixed-citation>
</ref>
<ref id="R50">
<label>50.</label>
<mixed-citation publication-type="journal"><name><surname>Koolen</surname><given-names>DA</given-names></name>
<etal></etal>
<article-title>The Koolen-de Vries syndrome: a phenotypic comparison of patients
with a 17q21.31 microdeletion versus a KANSL1 sequence
variant</article-title>. <source/>Eur J Hum Genet
<volume>24</volume>, <fpage>652</fpage>–<lpage>9</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">26306646</pub-id></mixed-citation>
</ref>
<ref id="R51">
<label>51.</label>
<mixed-citation publication-type="book"><name><surname>Phelan</surname><given-names>K</given-names></name> &amp; <name><surname>Rogers</surname><given-names>RC</given-names></name>
<chapter-title>Phelan-McDermid Syndrome</chapter-title> in
<source/>GeneReviews(R) (eds. <name><surname>Adam</surname><given-names>MP</given-names></name> et al.) (<publisher-loc>Seattle (WA</publisher-loc>),
<year>1993</year>).</mixed-citation>
</ref>
<ref id="R52">
<label>52.</label>
<mixed-citation publication-type="journal"><name><surname>Bi</surname><given-names>W</given-names></name>
<etal></etal>
<article-title>Mutations of RAI1, a PHD-containing protein, in nondeletion
patients with Smith-Magenis syndrome</article-title>. <source/>Hum
Genet
<volume>115</volume>, <fpage>515</fpage>–<lpage>24</lpage>
(<year>2004</year>).<pub-id pub-id-type="pmid">15565467</pub-id></mixed-citation>
</ref>
<ref id="R53">
<label>53.</label>
<mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>JY</given-names></name>
<etal></etal>
<article-title>Identification of a novel de novo nonsense mutation of the NSD1
gene in monozygotic twins discordant for Sotos syndrome</article-title>.
<source/>Clin Chim Acta
<volume>470</volume>, <fpage>31</fpage>–<lpage>35</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28457852</pub-id></mixed-citation>
</ref>
<ref id="R54">
<label>54.</label>
<mixed-citation publication-type="journal"><name><surname>Izumi</surname><given-names>K</given-names></name>
<etal></etal>
<article-title>Interstitial microdeletion of 4p16.3: contribution of WHSC1
haploinsufficiency to the pathogenesis of developmental delay in
Wolf-Hirschhorn syndrome</article-title>. <source/>Am J Med Genet A
<volume>152A</volume>, <fpage>1028</fpage>–<lpage>32</lpage>
(<year>2010</year>).<pub-id pub-id-type="pmid">20358621</pub-id></mixed-citation>
</ref>
<ref id="R55">
<label>55.</label>
<mixed-citation publication-type="journal"><name><surname>Shimbo</surname><given-names>H</given-names></name>
<etal></etal>
<article-title>Haploinsufficiency of BCL11A associated with cerebellar
abnormalities in 2p15p16.1 deletion syndrome</article-title>. <source/>Mol
Genet Genomic Med
<volume>5</volume>, <fpage>429</fpage>–<lpage>437</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28717667</pub-id></mixed-citation>
</ref>
<ref id="R56">
<label>56.</label>
<mixed-citation publication-type="journal"><name><surname>Kleefstra</surname><given-names>T</given-names></name>
<etal></etal>
<article-title>Further clinical and molecular delineation of the 9q subtelomeric
deletion syndrome supports a major contribution of EHMT1 haploinsufficiency
to the core phenotype</article-title>. <source/>J Med Genet
<volume>46</volume>, <fpage>598</fpage>–<lpage>606</lpage>
(<year>2009</year>).<pub-id pub-id-type="pmid">19264732</pub-id></mixed-citation>
</ref>
<ref id="R57">
<label>57.</label>
<mixed-citation publication-type="journal"><name><surname>Fergelot</surname><given-names>P</given-names></name>
<etal></etal>
<article-title>Phenotype and genotype in 52 patients with Rubinstein-Taybi
syndrome caused by EP300 mutations</article-title>. <source/>Am J Med Genet
A
<volume>170</volume>, <fpage>3069</fpage>–<lpage>3082</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27648933</pub-id></mixed-citation>
</ref>
<ref id="R58">
<label>58.</label>
<mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>RA</given-names></name>
<etal></etal>
<article-title>Recurrent 16p11.2 microdeletions in autism</article-title>.
<source/>Hum Mol Genet
<volume>17</volume>, <fpage>628</fpage>–<lpage>38</lpage>
(<year>2008</year>).<pub-id pub-id-type="pmid">18156158</pub-id></mixed-citation>
</ref>
<ref id="R59">
<label>59.</label>
<mixed-citation publication-type="journal"><name><surname>Labonne</surname><given-names>JD</given-names></name>
<etal></etal>
<article-title>A microdeletion encompassing PHF21A in an individual with global
developmental delay and craniofacial anomalies</article-title>. <source/>Am J
Med Genet A
<volume>167A</volume>, <fpage>3011</fpage>–<lpage>8</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">26333423</pub-id></mixed-citation>
</ref>
<ref id="R60">
<label>60.</label>
<mixed-citation publication-type="journal"><name><surname>McCool</surname><given-names>C</given-names></name>, <name><surname>Spinks-Franklin</surname><given-names>A</given-names></name>, <name><surname>Noroski</surname><given-names>LM</given-names></name> &amp; <name><surname>Potocki</surname><given-names>L</given-names></name>
<article-title>Potocki-Shaffer syndrome in a child without intellectual
disability-The role of PHF21A in cognitive function</article-title>.
<source/>Am J Med Genet A
<volume>173</volume>, <fpage>716</fpage>–<lpage>720</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28127865</pub-id></mixed-citation>
</ref>
<ref id="R61">
<label>61.</label>
<mixed-citation publication-type="journal"><name><surname>Leroy</surname><given-names>C</given-names></name>
<etal></etal>
<article-title>The 2q37-deletion syndrome: an update of the clinical spectrum
including overweight, brachydactyly and behavioural features in 14 new
patients</article-title>. <source/>Eur J Hum Genet
<volume>21</volume>, <fpage>602</fpage>–<lpage>12</lpage>
(<year>2013</year>).<pub-id pub-id-type="pmid">23073310</pub-id></mixed-citation>
</ref>
<ref id="R62">
<label>62.</label>
<mixed-citation publication-type="journal"><name><surname>Klebe</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>KIF1A missense mutations in SPG30, an autosomal recessive spastic
paraplegia: distinct phenotypes according to the nature of the
mutations</article-title>. <source/>Eur J Hum Genet
<volume>20</volume>, <fpage>645</fpage>–<lpage>9</lpage>
(<year>2012</year>).<pub-id pub-id-type="pmid">22258533</pub-id></mixed-citation>
</ref>
<ref id="R63">
<label>63.</label>
<mixed-citation publication-type="journal"><name><surname>Halder</surname><given-names>D</given-names></name>
<etal></etal>
<article-title>Suppression of Sin3A activity promotes differentiation of
pluripotent cells into functional neurons</article-title>. <source/>Sci
Rep
<volume>7</volume>, <fpage>44818</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28303954</pub-id></mixed-citation>
</ref>
<ref id="R64">
<label>64.</label>
<mixed-citation publication-type="journal"><name><surname>Witteveen</surname><given-names>JS</given-names></name>
<etal></etal>
<article-title>Haploinsufficiency of MeCP2-interacting transcriptional
co-repressor SIN3A causes mild intellectual disability by affecting the
development of cortical integrity</article-title>. <source/>Nat
Genet
<volume>48</volume>, <fpage>877</fpage>–<lpage>87</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27399968</pub-id></mixed-citation>
</ref>
<ref id="R65">
<label>65.</label>
<mixed-citation publication-type="journal"><name><surname>Amir</surname><given-names>RE</given-names></name>
<etal></etal>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding
methyl-CpG-binding protein 2</article-title>. <source/>Nat Genet
<volume>23</volume>, <fpage>185</fpage>–<lpage>8</lpage>
(<year>1999</year>).<pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="R66">
<label>66.</label>
<mixed-citation publication-type="journal"><name><surname>Jansen</surname><given-names>S</given-names></name>
<etal></etal>
<article-title>De Novo Truncating Mutations in the Last and Penultimate Exons of
PPM1D Cause an Intellectual Disability Syndrome</article-title>. <source/>Am
J Hum Genet
<volume>100</volume>, <fpage>650</fpage>–<lpage>658</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28343630</pub-id></mixed-citation>
</ref>
<ref id="R67">
<label>67.</label>
<mixed-citation publication-type="journal"><name><surname>DeMari</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>CLTC as a clinically novel gene associated with multiple
malformations and developmental delay</article-title>. <source/>Am J Med
Genet A
<volume>170A</volume>, <fpage>958</fpage>–<lpage>66</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">26822784</pub-id></mixed-citation>
</ref>
<ref id="R68">
<label>68.</label>
<mixed-citation publication-type="journal"><name><surname>Fusco</surname><given-names>C</given-names></name>
<etal></etal>
<article-title>Smaller and larger deletions of the Williams Beuren syndrome
region implicate genes involved in mild facial phenotype, epilepsy and
autistic traits</article-title>. <source/>Eur J Hum Genet
<volume>22</volume>, <fpage>64</fpage>–<lpage>70</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">23756441</pub-id></mixed-citation>
</ref>
<ref id="R69">
<label>69.</label>
<mixed-citation publication-type="journal"><name><surname>Buxbaum</surname><given-names>JD</given-names></name>
<etal></etal>
<article-title>Association between a GABRB3 polymorphism and
autism</article-title>. <source/>Mol Psychiatry
<volume>7</volume>, <fpage>311</fpage>–<lpage>6</lpage>
(<year>2002</year>).<pub-id pub-id-type="pmid">11920158</pub-id></mixed-citation>
</ref>
<ref id="R70">
<label>70.</label>
<mixed-citation publication-type="journal"><name><surname>Guella</surname><given-names>I</given-names></name>
<etal></etal>
<article-title>De Novo Mutations in YWHAG Cause Early-Onset
Epilepsy</article-title>. <source/>Am J Hum Genet
<volume>101</volume>, <fpage>300</fpage>–<lpage>310</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28777935</pub-id></mixed-citation>
</ref>
<ref id="R71">
<label>71.</label>
<mixed-citation publication-type="journal"><name><surname>Asadollahi</surname><given-names>R</given-names></name>
<etal></etal>
<article-title>The clinical significance of small copy number variants in
neurodevelopmental disorders</article-title>. <source/>J Med Genet
<volume>51</volume>, <fpage>677</fpage>–<lpage>88</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">25106414</pub-id></mixed-citation>
</ref>
<ref id="R72">
<label>72.</label>
<mixed-citation publication-type="journal"><name><surname>Harrington</surname><given-names>AJ</given-names></name>
<etal></etal>
<article-title>MEF2C regulates cortical inhibitory and excitatory synapses and
behaviors relevant to neurodevelopmental disorders</article-title>.
<source/>Elife
<volume>5</volume>(<year>2016</year>).</mixed-citation>
</ref>
<ref id="R73">
<label>73.</label>
<mixed-citation publication-type="journal"><name><surname>Paciorkowski</surname><given-names>AR</given-names></name>
<etal></etal>
<article-title>MEF2C Haploinsufficiency features consistent hyperkinesis,
variable epilepsy, and has a role in dorsal and ventral neuronal
developmental pathways</article-title>. <source/>Neurogenetics
<volume>14</volume>, <fpage>99</fpage>–<lpage>111</lpage>
(<year>2013</year>).<pub-id pub-id-type="pmid">23389741</pub-id></mixed-citation>
</ref>
<ref id="R74">
<label>74.</label>
<mixed-citation publication-type="journal"><name><surname>Kohannim</surname><given-names>O</given-names></name>
<etal></etal>
<article-title>Discovery and Replication of Gene Influences on Brain Structure
Using LASSO Regression</article-title>. <source/>Front Neurosci
<volume>6</volume>, <fpage>115</fpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22888310</pub-id></mixed-citation>
</ref>
<ref id="R75">
<label>75.</label>
<mixed-citation publication-type="journal"><name><surname>Weiss</surname><given-names>K</given-names></name>
<etal></etal>
<article-title>De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler
Gene, Cause an Intellectual Disability Syndrome with Distinctive
Dysmorphisms</article-title>. <source/>Am J Hum Genet
<volume>99</volume>, <fpage>934</fpage>–<lpage>941</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27616479</pub-id></mixed-citation>
</ref>
<ref id="R76">
<label>76.</label>
<mixed-citation publication-type="journal"><name><surname>Berko</surname><given-names>ER</given-names></name>
<etal></etal>
<article-title>De novo missense variants in HECW2 are associated with
neurodevelopmental delay and hypotonia</article-title>. <source/>J Med
Genet
<volume>54</volume>, <fpage>84</fpage>–<lpage>86</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">27389779</pub-id></mixed-citation>
</ref>
<ref id="R77">
<label>77.</label>
<mixed-citation publication-type="journal"><name><surname>Harripaul</surname><given-names>R</given-names></name>
<etal></etal>
<article-title>Mapping autosomal recessive intellectual disability: combined
microarray and exome sequencing identifies 26 novel candidate genes in 192
consanguineous families</article-title>. <source/>Mol Psychiatry
(<year>2017</year>).</mixed-citation>
</ref>
<ref id="R78">
<label>78.</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Moore</surname><given-names>MJ</given-names></name>, <name><surname>Adelmant</surname><given-names>G</given-names></name>, <name><surname>Marto</surname><given-names>JA</given-names></name> &amp; <name><surname>Silver</surname><given-names>PA</given-names></name>
<article-title>PQBP1, a factor linked to intellectual disability, affects
alternative splicing associated with neurite outgrowth</article-title>.
<source/>Genes Dev
<volume>27</volume>, <fpage>615</fpage>–<lpage>26</lpage>
(<year>2013</year>).<pub-id pub-id-type="pmid">23512658</pub-id></mixed-citation>
</ref>
<ref id="R79">
<label>79.</label>
<mixed-citation publication-type="journal"><name><surname>Levy</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>Molecular and clinical delineation of 2p15p16.1 microdeletion
syndrome</article-title>. <source/>Am J Med Genet A
<volume>173</volume>, <fpage>2081</fpage>–<lpage>2087</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28573701</pub-id></mixed-citation>
</ref>
<ref id="R80">
<label>80.</label>
<mixed-citation publication-type="journal"><name><surname>Dheedene</surname><given-names>A</given-names></name>, <name><surname>Maes</surname><given-names>M</given-names></name>, <name><surname>Vergult</surname><given-names>S</given-names></name> &amp; <name><surname>Menten</surname><given-names>B</given-names></name>
<article-title>A de novo POU3F3 Deletion in a Boy with Intellectual Disability
and Dysmorphic Features</article-title>. <source/>Mol Syndromol
<volume>5</volume>, <fpage>32</fpage>–<lpage>5</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">24550763</pub-id></mixed-citation>
</ref>
<ref id="R81">
<label>81.</label>
<mixed-citation publication-type="journal"><name><surname>Carlston</surname><given-names>CM</given-names></name>
<etal></etal>
<article-title>Pathogenic ASXL1 somatic variants in reference databases
complicate germline variant interpretation for Bohring-Opitz
Syndrome</article-title>. <source/>Hum Mutat
<volume>38</volume>, <fpage>517</fpage>–<lpage>523</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28229513</pub-id></mixed-citation>
</ref>
<ref id="R82">
<label>82.</label>
<mixed-citation publication-type="journal"><name><surname>He</surname><given-names>X</given-names></name>
<etal></etal>
<article-title>Integrated model of de novo and inherited genetic variants yields
greater power to identify risk genes</article-title>. <source/>PLoS
Genet
<volume>9</volume>, <fpage>e1003671</fpage>
(<year>2013</year>).<pub-id pub-id-type="pmid">23966865</pub-id></mixed-citation>
</ref>
<ref id="R83">
<label>83.</label>
<mixed-citation publication-type="journal"><name><surname>Werling</surname><given-names>DM</given-names></name>
<etal></etal>
<article-title>Limited contribution of rare, noncoding variation to autism
spectrum disorder from sequencing of 2,076 genomes in quartet
families</article-title>. <source/>BioRxiv
(<year>2017</year>).</mixed-citation>
</ref>
<ref id="R84">
<label>84.</label>
<mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>TN</given-names></name>
<etal></etal>
<article-title>Genomic Patterns of De Novo Mutation in Simplex
Autism</article-title>. <source/>Cell
(<year>2017</year>).</mixed-citation>
</ref>
<ref id="R85">
<label>85.</label>
<mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>SM</given-names></name>, <name><surname>Park</surname><given-names>HR</given-names></name> &amp; <name><surname>Lee</surname><given-names>JH</given-names></name>
<article-title>MAPK3 at the Autism-Linked Human 16p11.2 Locus Influences Precise
Synaptic Target Selection at Drosophila Larval Neuromuscular
Junctions</article-title>. <source/>Mol Cells
<volume>40</volume>, <fpage>151</fpage>–<lpage>161</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28196412</pub-id></mixed-citation>
</ref>
<ref id="R86">
<label>86.</label>
<mixed-citation publication-type="journal"><name><surname>Pucilowska</surname><given-names>J</given-names></name>
<etal></etal>
<article-title>The 16p11.2 deletion mouse model of autism exhibits altered
cortical progenitor proliferation and brain cytoarchitecture linked to the
ERK MAPK pathway</article-title>. <source/>J Neurosci
<volume>35</volume>, <fpage>3190</fpage>–<lpage>200</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">25698753</pub-id></mixed-citation>
</ref>
<ref id="R87">
<label>87.</label>
<mixed-citation publication-type="journal"><name><surname>Blizinsky</surname><given-names>KD</given-names></name>
<etal></etal>
<article-title>Reversal of dendritic phenotypes in 16p11.2 microduplication
mouse model neurons by pharmacological targeting of a network
hub</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>113</volume>, <fpage>8520</fpage>–<lpage>5</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27402753</pub-id></mixed-citation>
</ref>
<ref id="R88">
<label>88.</label>
<mixed-citation publication-type="journal"><name><surname>Langen</surname><given-names>M</given-names></name>
<etal></etal>
<article-title>Changes in the development of striatum are involved in repetitive
behavior in autism</article-title>. <source/>Biol Psychiatry
<volume>76</volume>, <fpage>405</fpage>–<lpage>11</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">24090791</pub-id></mixed-citation>
</ref>
<ref id="R89">
<label>89.</label>
<mixed-citation publication-type="journal"><name><surname>Platt</surname><given-names>RJ</given-names></name>
<etal></etal>
<article-title>Chd8 Mutation Leads to Autistic-like Behaviors and Impaired
Striatal Circuits</article-title>. <source/>Cell Rep
<volume>19</volume>, <fpage>335</fpage>–<lpage>350</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28402856</pub-id></mixed-citation>
</ref>
<ref id="R90">
<label>90.</label>
<mixed-citation publication-type="journal"><name><surname>Reim</surname><given-names>D</given-names></name>
<etal></etal>
<article-title>Proteomic Analysis of Post-synaptic Density Fractions from Shank3
Mutant Mice Reveals Brain Region Specific Changes Relevant to Autism
Spectrum Disorder</article-title>. <source/>Front Mol Neurosci
<volume>10</volume>, <fpage>26</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28261056</pub-id></mixed-citation>
</ref>
<ref id="R91">
<label>91.</label>
<mixed-citation publication-type="journal"><name><surname>Balsters</surname><given-names>JH</given-names></name>, <name><surname>Mantini</surname><given-names>D</given-names></name> &amp; <name><surname>Wenderoth</surname><given-names>N</given-names></name>
<article-title>Connectivity-based parcellation reveals distinct cortico-striatal
connectivity fingerprints in Autism Spectrum Disorder</article-title>.
<source/>Neuroimage (<year>2017</year>).</mixed-citation>
</ref>
<ref id="R92">
<label>92.</label>
<mixed-citation publication-type="journal"><name><surname>Shohat</surname><given-names>S</given-names></name>, <name><surname>Ben-David</surname><given-names>E</given-names></name> &amp; <name><surname>Shifman</surname><given-names>S</given-names></name>
<article-title>Varying Intolerance of Gene Pathways to Mutational Classes
Explain Genetic Convergence across Neuropsychiatric
Disorders</article-title>. <source/>Cell Rep
<volume>18</volume>, <fpage>2217</fpage>–<lpage>2227</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28249166</pub-id></mixed-citation>
</ref>
<ref id="R93">
<label>93.</label>
<mixed-citation publication-type="journal"><name><surname>Kaya</surname><given-names>N</given-names></name>
<etal></etal>
<article-title>KCNA4 deficiency leads to a syndrome of abnormal striatum,
congenital cataract and intellectual disability</article-title>. <source/>J
Med Genet (<year>2016</year>).</mixed-citation>
</ref>
<ref id="R94">
<label>94.</label>
<mixed-citation publication-type="journal"><name><surname>Flanigan</surname><given-names>M</given-names></name> &amp; <name><surname>LeClair</surname><given-names>K</given-names></name>
<article-title>Shared Motivational Functions of Ventral Striatum D1 and D2
Medium Spiny Neurons</article-title>. <source/>J Neurosci
<volume>37</volume>, <fpage>6177</fpage>–<lpage>6179</lpage>
(<year>2017</year>).<pub-id pub-id-type="pmid">28659329</pub-id></mixed-citation>
</ref>
<ref id="R95">
<label>95.</label>
<mixed-citation publication-type="journal"><name><surname>Sanders</surname><given-names>SJ</given-names></name>
<article-title>First glimpses of the neurobiology of autism spectrum
disorder</article-title>. <source/>Curr Opin Genet Dev
<volume>33</volume>, <fpage>80</fpage>–<lpage>92</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">26547130</pub-id></mixed-citation>
</ref>
<ref id="R96">
<label>96.</label>
<mixed-citation publication-type="journal"><name><surname>Schreiweis</surname><given-names>C</given-names></name>
<etal></etal>
<article-title>Humanized Foxp2 accelerates learning by enhancing transitions
from declarative to procedural performance</article-title>. <source/>Proc
Natl Acad Sci U S A
<volume>111</volume>, <fpage>14253</fpage>–<lpage>8</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">25225386</pub-id></mixed-citation>
</ref>
<ref id="R97">
<label>97.</label>
<mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>YC</given-names></name>
<etal></etal>
<article-title>Foxp2 controls synaptic wiring of corticostriatal circuits and
vocal communication by opposing Mef2c</article-title>. <source/>Nat
Neurosci
<volume>19</volume>, <fpage>1513</fpage>–<lpage>1522</lpage>
(<year>2016</year>).<pub-id pub-id-type="pmid">27595386</pub-id></mixed-citation>
</ref>
<ref id="R98">
<label>98.</label>
<mixed-citation publication-type="journal"><name><surname>Stessman</surname><given-names>HA</given-names></name>, <name><surname>Bernier</surname><given-names>R</given-names></name> &amp; <name><surname>Eichler</surname><given-names>EE</given-names></name>
<article-title>A genotype-first approach to defining the subtypes of a complex
disease</article-title>. <source/>Cell
<volume>156</volume>, <fpage>872</fpage>–<lpage>7</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">24581488</pub-id></mixed-citation>
</ref>
<ref id="R99">
<label>99.</label>
<mixed-citation publication-type="journal"><name><surname>Bernier</surname><given-names>R</given-names></name>
<etal></etal>
<article-title>Disruptive CHD8 mutations define a subtype of autism early in
development</article-title>. <source/>Cell
<volume>158</volume>, <fpage>263</fpage>–<lpage>276</lpage>
(<year>2014</year>).<pub-id pub-id-type="pmid">24998929</pub-id></mixed-citation>
</ref>
</ref-list>
<ref-list>
<title>METHODS ONLY REFERENCES</title>
<ref id="R100">
<label>100.</label>
<mixed-citation publication-type="journal"><name><surname>Warde-Farley</surname><given-names>D</given-names></name>
<etal></etal>
<article-title>The GeneMANIA prediction server: biological network integration
for gene prioritization and predicting gene function</article-title>.
<source/>Nucleic Acids Res
<volume>38</volume>, <fpage>W214</fpage>–<lpage>20</lpage>
(<year>2010</year>).<pub-id pub-id-type="pmid">20576703</pub-id></mixed-citation>
</ref>
<ref id="R101">
<label>101.</label>
<mixed-citation publication-type="journal"><name><surname>Zeisel</surname><given-names>A</given-names></name>
<etal></etal>
<article-title>Brain structure. Cell types in the mouse cortex and hippocampus
revealed by single-cell RNA-seq</article-title>. <source/>Science
<volume>347</volume>, <fpage>1138</fpage>–<lpage>42</lpage>
(<year>2015</year>).<pub-id pub-id-type="pmid">25700174</pub-id></mixed-citation>
</ref>
<ref id="R102">
<label>102.</label>
<mixed-citation publication-type="journal"><name><surname>Dobin</surname><given-names>A</given-names></name>
<etal></etal>
<article-title>STAR: ultrafast universal RNA-seq aligner</article-title>.
<source/>Bioinformatics
<volume>29</volume>, <fpage>15</fpage>–<lpage>21</lpage>
(<year>2013</year>).<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1:</label>
<caption>
<title><italic>de novo</italic> enriched genes and their characteristics.</title>
<p id="P49">Shown are the results of applying both the chimpanzee-human (CH)
divergence model and denovolyzeR to <italic>de novo</italic> variation in n =
10,927 independent individuals with ASD/ID/DD. The two models show considerable
gene overlap <bold>(A,B)</bold> with correlated significance values (LGD Pearson
r<sup>2</sup> = 0.94, missense r<sup>2</sup> = 0.74) <bold>(C,D)</bold>. CH
model LGD outliers include <italic>NONO</italic>, <italic>MEIS2</italic>,
<italic>LEO1</italic>, <italic>WDR26</italic>, and <italic>CAPRIN1</italic>,
and denovolyzeR LGD outliers include <italic>ZBTB18</italic> and
<italic>FAM200B</italic>
<bold>(C)</bold>. CH model missense (MIS) outliers include
<italic>CAPN15</italic>, <italic>SNAPC5</italic>, <italic>DLX3</italic>,
<italic>TMEM178A</italic>, <italic>ADAP1</italic>, <italic>SNX5</italic>,
<italic>SMARCD1</italic>, <italic>WDR26</italic>, and <italic>AGO4</italic>,
and denovolyzeR missense outliers include <italic>ITPR1</italic>,
<italic>RAC1</italic>, <italic>SETD1B</italic>, <italic>WDFY4</italic>, and
<italic>UNC80</italic>
<bold>(D)</bold>. Recurrent mutated LGD genes (TRUE, n = 145 with pLI scores)
are highly enriched for genes intolerant to mutation as defined by ExAC pLI
score (two-tailed Wilcoxon rank-sum test) <bold>(E)</bold>. Genes significantly
enriched for missense DNMs (n = 118 with missense Z scores) are outliers by the
ExAC missense depletion Z scores (two-tailed Wilcoxon rank-sum test)
<bold>(F)</bold>. Similarly, all subcategories of significant genes (n below
each category name) are intolerant to mutation (RVIS percentile) when compared
to non-significant genes (Tukey HSD test, p-values are corrected for all
possible group comparisons) <bold>(G)</bold>. Boxplots represent Quartiles 1 to
3 with the median indicated. Whiskers span from Q1 - 1.5 IQR to Q3 + 1.5
IQR.</p>
</caption>
<graphic xlink:href="nihms-1510455-f0001"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2:</label>
<caption>
<title>Gene expression and protein-interaction networks.</title>
<p id="P50">(A-D) MAGI<sup><xref ref-type="bibr" rid="R43">43</xref></sup> analysis
of the union set (n = 253 independent genes) highlights the top four modules of
co-expression and protein-protein interaction (PPI), including genes significant
for DNM enrichment by denovolyzeR (FDR-adjusted Poisson test) or the CH model
(FDR-adjusted binomial test) (colored circles) and new candidate genes with DNM
that do not yet reach significance (dark gray). The size of the circle
represents the relative number of patients with DNMs within this cohort. Edges
depict PPIs (pink arcs) and co-expression (green arcs) scaled by their scores
from geneMANIA<sup><xref ref-type="bibr" rid="R100">100</xref></sup>.
<bold>(E)</bold> Tissue-specific enrichment analyses (TSEA) of the union set
(n = 253 independent genes) highlight a strong bias to various developing parts
of the brain with the strongest signal early to mid-fetal development (color
corresponds to FDR-adjusted one-tailed Fisher’s exact test p-values,
shaded regions closer to the center of each hexagon indicate increasing tissue
specificity).</p>
</caption>
<graphic xlink:href="nihms-1510455-f0002"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3:</label>
<caption>
<title>Expression in human cortical neurons.</title>
<p id="P51"><bold>(A-B)</bold> Heatmaps demonstrating a broad pattern of inhibitory
and excitatory neuronal expression (median log<sub>2</sub> (CPM+1)) in the union
gene set (n = 253 independent genes) compared to control genes (n = 156
independent genes). Expression level is indicated by a color gradient from low
expression (dark blue) to high (orange). Rows represent individual genes and are
ordered by the number of clusters (transcriptomic defined cell types) with
expression (median CPM &gt; 1), and columns represent 41 inhibitory
neuronal, 24 excitatory neuronal, and 6 glial transcriptional clusters, each
representing a distinct cell type. <bold>(C-D)</bold> The number of inhibitory
and excitatory clusters with expression in NDD genes (Union n = 253, LGD n =
145, MIS n = 123, MIS30 n = 59) compared to controls (synonymous (SYN) n = 101,
Control n = 156 independent genes). The signal is strongest for NDD genes with
the most severe missense mutations (MIS30). Boxplots represent Quartiles 1 to 3
with the median indicated. Whiskers span from Q1 - 1.5 IQR to Q3 + 1.5 IQR.</p>
</caption>
<graphic xlink:href="nihms-1510455-f0003"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4:</label>
<caption>
<title>Estimation of gene discovery rates in future cohorts.</title>
<p id="P52">We estimate the number of genes reaching significance under the CH model
at varying population sizes subsampled from the total cohort of 10,927
individuals. Both the number of significant genes with recurrent LGD and MIS30
DNMs appear to be saturating with limited new gene discovery as sample sizes
grow. <italic>De novo</italic> missense variants (including MIS30), however, as
a more general class demonstrate a more complex growth pattern with no best-fit
line and, thus, likely represent the most important reservoir for new gene
discovery as sequence data are generated from additional ASD and DD cohorts.</p>
</caption>
<graphic xlink:href="nihms-1510455-f0004"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Figure 5:</label>
<caption>
<title>Integration of <italic>de novo</italic> SNVs and CNV morbidity map.</title>
<p id="P53">Shown are examples of pathogenic CNVs (blue, red and purple shading)
associated with genomic disorders from chromosomes 15, 16, and 17, which
intersect with genes that show a significant excess of DNM in n = 10,927
independent patients (red, turquoise and blue points representing the minimum
q-value from either denovolyzeR or CH model, the dashed line represents a
q-value of 0.05). The analysis confirms known associations, such as
<italic>RAI1</italic>, and <italic>KANSL1</italic> and candidate association
for <italic>MAPK3</italic>. Recurrent severe missense mutations of
<italic>GABRB3</italic> have been associated with autism and may be relevant
to the recurrent 15q11 duplication. We note that mutations and deletions of the
imprinted genes <italic>SNRPN</italic> (no DNM in our data set) and
<italic>UBE3A</italic> (1 LGD and 1 missense DNM in our data set) are known
to cause the core phenotype of Prader-Willi and Angelman syndromes,
respectively, but do not reach significance in this analysis.</p>
</caption>
<graphic xlink:href="nihms-1510455-f0005"></graphic>
</fig>
<table-wrap id="T1" orientation="landscape" position="float">
<label>Table 1:</label>
<caption>
<p id="P54">Recurrent DNM gene summary and model comparison.</p>
</caption>
<table frame="void" rules="cols">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="7" rowspan="1" valign="bottom">
<hr/>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="center" colspan="1" rowspan="1" valign="bottom">ID/DD Only</th>
<th align="center" colspan="1" rowspan="1" valign="bottom">ASD Only</th>
</tr>
<tr>
<th align="left" colspan="7" rowspan="1" valign="bottom">
<hr/>
</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" valign="middle">Variant Category</th>
<th align="center" colspan="1" rowspan="1" valign="middle">CH Model Count</th>
<th align="center" colspan="1" rowspan="1" valign="middle">denovolyzeR Count</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Union Count (FDR (FWER))</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Intersection Count (FDR (FWER))</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Union Count (FDR (FWER))</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Union Count (FDR (FWER))</th>
</tr>
<tr>
<th align="left" colspan="7" rowspan="1" valign="bottom">
<hr/>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>LGD &amp; MIS30 &amp;
Missense</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">14</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">NA</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">14 (5)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">
<italic>NA</italic>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">4 (1)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>LGD &amp; MIS30</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">NA</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">1 (3)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">
<italic>NA</italic>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">0 (0)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>LGD &amp; Missense</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">13</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">22</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">15 (6)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">21 (8)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">19 (10)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">3 (1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>LGD</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">92</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">108</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">115 (62)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">85 (49)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">95 (55)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">31 (14)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>MIS30 &amp; Missense</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">28</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">NA</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">31 (18)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">
<italic>NA</italic>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">9 (7)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>MIS30</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">16</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">NA</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">14 (10)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">
<italic>NA</italic>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">0 (0)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">0 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>Missense</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">46</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">63</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">63 (20)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">42 (22)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">56 (25)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">7 (3)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="bottom">
<hr/>
</td>
</tr>
<tr>
<td align="right" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>total</italic>
</bold>
</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">210</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">193</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">253 (124)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">148 (79)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">183 (98)</td>
<td align="right" colspan="1" rowspan="1" valign="bottom">41 (18)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN1">
<p id="P55">The number of genes reaching statistical significance for DNM
enrichment in n = 10,927 independent samples by the CH model and denovolyzeR
as well as the unions and intersections of these gene sets are shown for
each mutation category (LGD, Missense, MIS30). Also shown are the union
counts for the ASD (n = 5,624 independent samples) and ID/DD (n = 5,303)
only analyses. Counts represent genes passing an FDR q-value threshold of
0.05. Bracketed numbers represent genes passing a Bonferroni FWER correction
(p &lt; 5e-7).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" orientation="landscape" position="float">
<label>Table 2:</label>
<caption>
<p id="P56">Genes enriched for <italic>de novo</italic> variation in 10,927
ASD/ID/DD patients in denovo-db v.1.5.</p>
</caption>
<table frame="box" rules="all">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Significance Category</th>
<th align="left" colspan="1" rowspan="1" valign="top">Genes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADNP</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, AHDC1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ANK2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ANKRD11</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ANP32A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
</sup>
<italic>, ARID1B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ARID2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ASH1L</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ASXL1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ASXL3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, AUTS2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
BCL11A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, BRPF1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CAPRIN1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CASZ1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CDC42BPB</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CDKL5</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CHAMP1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CHD7</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CHD8</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CLTC</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CNKSR2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CNOT3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CTNNB1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CUL3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, DLG4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
DSCAM</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, DVL3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
EBF3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, EHMT1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ENO3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, EP300</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, FAM200A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
FAM200B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, FOSL2, FOXP2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
GATAD2B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, HIST1H1E</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
HIVEP2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, HIVEP3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
HNRNPD</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, IRF2BPL</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KANSL1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KAT6A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KAT6B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KCNS3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KDM5B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KDM6A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KDM6B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KIAA2022</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KIF11</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KMT2A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KMT2C</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
LARP4B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, LEO1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
MBD5</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, MEIS2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, MSL3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
NAA15</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, NFE2L3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
NONO</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, NSD1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ODC1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PDHA1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PHF12</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PHF21A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PHF3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PHIP</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, POU3F3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PPM1D</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PRR12</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PTCHD1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, QRICH1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
RAI1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, RPL26</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SET</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SETBP1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SETD2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SETD5</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SHANK3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SIN3A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SKIDA1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SMC1A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SON</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SOX5</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SPAST</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SPEN</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SPRY2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SRCAP</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SRRM2,
SRSF11</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, STARD9</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SUV420H1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SYNCRIP</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SYNGAP1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, TAB2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TBR1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, TCF12</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TCF20</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, TNRC6B, TRA2B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TRIP12</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, UPF3B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, USP9X</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, VEZF1,
WAC</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
WDFY3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, WDR45</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
WDR87</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, WHSC1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
YTHDF3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ZBTB18</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ZBTB7A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ZC4H2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ZNF292</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">LGD &amp; Missense</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CHD2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CREBBP</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
DYRK1A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, FBXO11</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
FOXG1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, FOXP1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, HNRNPU</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
MEF2C</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, MYT1L</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, NFIX</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
POGZ</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PTEN</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PURA</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TLK2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, WDR26</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">LGD &amp; MIS30</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TCF7L2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">LGD &amp; Missense &amp; MIS30</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CASK</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, DDX3X</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
HDAC8</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, IQSEC2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, MECP2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
MED13L</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PPP2R5D</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PUF60</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SATB2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SCN2A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SLC6A1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, STXBP1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, TBL1XR1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TCF4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Missense</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABI2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ACHE</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ADAP1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
AGAP2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, AGO1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
AGO4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
AQP10</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, BRAF</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
BTF3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, C2orf42</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CABP7</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CAPN15</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CBL</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CHD4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CLASP1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, DEAF1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
DLX3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
DNM1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, EGLN2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
GABRB2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, GABRB3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
GLRA2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, GNAI1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
HMGXB3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, HUWE1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
ITPR1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KCNC1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KCNJ6</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, MAPK3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
MTF2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, MYO1E</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PBX1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PLAC8L1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PLK5</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PPP1CB</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PRKCA</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PRKD1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PRPF18</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PSMG4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PTPN11</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, RAC1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, RFX8</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
RRP8</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, RYR2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SETD1B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SF3B1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SHISA6</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SMAD4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SMARCD1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SMC3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SNAPC5</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SNX5</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SUSD4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SYT1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, TAOK1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TMEM178A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, TMEM42</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TNPO3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, TRAF7</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TRRAP</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, UNC80</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
VAMP2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, WDFY4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
YWHAG</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MIS30</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ACTC1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
AGO3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CACNA1E</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
FAM104A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, HIST1H2AC</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KIF5C</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PACS2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PAPOLG</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PDK2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SEPT10</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, STC1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TAF1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TNPO2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, U2AF2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Missense &amp; MIS30</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CDK13</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CHD3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
COL4A3BP</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, CSNK2A1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
CTCF</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, DNMT3A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, DYNC1H1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
EEF1A2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, EFTUD2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, GNAO1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
GRIN2B</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, HECW2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KCND3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KCNH1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KCNQ2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, KCNQ3</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
KIF1A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, MAP2K1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, NAA10</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
NR2F1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, NR4A2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
PACS1</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PIK3CA</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, PPP2R1A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
RAB11A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SCN8A</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
SMARCA2</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, SMARCA4</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>,
TRIO</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
<italic>, ZMYND11</italic>
<sup>
<xref ref-type="table-fn" rid="TFN4">*</xref>
<xref ref-type="table-fn" rid="TFN3">†</xref>
</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN2">
<p id="P57">Listing of genes reaching significance for excess of DNM in n =
10,927 independent samples at an FDR of 5% by either the denovolyzeR or CH
model (union) for each mutational category (LGD, Missense, MIS30).</p>
</fn>
<fn id="TFN3">
<label>†</label>
<p id="P58">Gene also in the intersection set.</p>
</fn>
<fn id="TFN4">
<label>*</label>
<p id="P59">Gene in FWER exome-wide significance (p&lt;5e-7) set.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" orientation="landscape" position="float">
<label>Table 3:</label>
<caption>
<p id="P60">Intersection between pathogenic CNVs and recurrently mutated genes.</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="center" colspan="9" rowspan="1" valign="bottom">denovo-db v.1.5
Counts<hr/></th>
<th align="center" colspan="1" rowspan="2" valign="middle">Union CH Model and
denovolyzeR</th>
<th align="center" colspan="4" rowspan="2" valign="middle">Genomic
Disorders</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="center" colspan="3" rowspan="1" valign="middle">LGD <italic>de novo</italic>
Variants</th>
<th align="center" colspan="3" rowspan="1" valign="middle">Missense <italic>de
novo</italic> Variants</th>
<th align="center" colspan="3" rowspan="1" valign="middle">MIS30 <italic>de
novo</italic> Variants</th>
</tr>
<tr>
<th align="left" colspan="16" rowspan="1" valign="bottom">
<hr/>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="center" colspan="1" rowspan="1" valign="middle">Gene Symbol*</th>
<th align="center" colspan="1" rowspan="1" valign="middle">All (n=10,927)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">ASD (n=5,624)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">ID/DD (n=5,303)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">All (n=10,927)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">ASD (n=5,624)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">ID/DD (n=5,303)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">All (n=10,927)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">ASD (n=5,624)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">ID/DD (n=5,303)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Significance (FDR ≤ 5%, count
&gt; 1)</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Deletion Syndrome</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Duplication Syndrome</th>
<th align="center" colspan="1" rowspan="1" valign="middle">CNV Significance Type<sup><xref ref-type="bibr" rid="R18">18</xref></sup></th>
<th align="center" colspan="1" rowspan="1" valign="middle">Decipher<xref ref-type="table-fn" rid="TFN6">†</xref> Classification</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="10" valign="middle"><bold>Significant in
Morbidity Map</bold><sup><xref ref-type="bibr" rid="R18">18</xref></sup>
<bold>(37 Disorders)</bold></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>MAPK3</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">16p11.2-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">16p11.2-duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL AND DUP</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>KANSL1</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>8</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">8</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">17q21.31-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">17q21.31-duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>KIF1A</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>11</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">10</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>9</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">9</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q37-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>EHMT1</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>9</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">9</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">9q34-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">9q34-duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL AND DUP</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>SHANK3</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>10</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">6</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Phelan-McDermid-syndrome-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL AND DUP</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>PHF21A</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Potocki-Shaffer-syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>GABRB3</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>6</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Prader-Willi/Angelman</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">PWS-duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL AND DUP</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>RAI1</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Smith-Magenis-syndrome-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Potocki-Lupski-syndrome-duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL AND DUP</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>NSD1</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>8</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">7</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>5</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Sotos-syndrome-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>WHSC1</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>4</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Wolf-Hirschhorn-deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">DEL AND DUP</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="20" valign="middle">
<bold>21 Additional Genomic
Disorders</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>SIN3A</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">15q24 deletion (A to E Inclusive)</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Other SD Pairs</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>CLTC</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>4</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">17q23 deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>PPM1D</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>8</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">7</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">17q23.1q23.2 deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>BCL11A</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>6</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2p15-16.1 microdeletion syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>PAPOLG</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS30</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2p15-16.1 microdeletion syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>POU3F3</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q11.2q13 deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>RFX8</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q11.2q13 deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>HECW2</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>9</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">7</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>7</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">5</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS30 &amp; MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q33.1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>SATB2<xref ref-type="table-fn" rid="TFN7">‡</xref></italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>9</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">9</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>6</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">6</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>5</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">5</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD &amp; MIS30 &amp; MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q33.1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>ABI2</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q33.1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>SF3B1</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>5</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q33.1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>CAPN15</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">ATR-16</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>SMC1A</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>8</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">8</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Xp11.22-linked ID</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>HUWE1</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>9</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">9</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Xp11.22-linked ID</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>WDR45</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>8</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">8</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Xp11.22-p11.23 microduplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>MECP2</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>11</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">7</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>7</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">7</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>4</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD &amp; MIS30 &amp; MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Xq28 (MECP2) duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<underline>
<bold>
<italic>CREBBP</italic>
</bold>
</underline>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>13</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">10</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD &amp; MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Rubinstein-Taybi syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Category 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>SUV420H1</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>7</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">3</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">SHANK2 FGFs deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">None</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>YWHAG</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>3</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Wms-distal deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Wms-distal duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>AUTS2</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>4</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Wms-prox deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Wms-prox duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="middle"><bold>14</bold>
Signific<bold>ant Regions</bold><sup><xref ref-type="bibr" rid="R18">18</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>SATB2<xref ref-type="table-fn" rid="TFN7">‡</xref></italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>9</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">9</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>6</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">6</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>5</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">5</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD &amp; MIS30 &amp; MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">2q33.1 (SATB2) deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>MEF2C</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>4</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>5</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">LGD &amp; MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">5q14 (MEF2C) deletion</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>CHD4</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>8</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">7</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>2</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">2</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">12p13 (SCNN1A to PIANP)</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="bottom">
<bold>
<italic>WDFY4</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>0</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>5</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">4</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">
<bold>1</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">0</td>
<td align="center" colspan="1" rowspan="1" valign="bottom">1</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">MIS</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom">1q11.23 duplication</td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
<td align="left" colspan="1" rowspan="1" valign="bottom"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN5">
<p id="P61">DNM counts and significance categories from n = 10,927 independent
samples are shown for genes from the union significance set (n = 253 genes
denovolyzeR or CH model FDR &lt; 5%) that intersect a previously
established genomic disorder region. Gene symbols with underlines represent
confirmation of known CNV associations. SD: segmental duplication</p>
</fn>
<fn id="TFN6">
<label>†</label>
<p id="P62">DECIPHER syndrome classification system; see <xref ref-type="sec" rid="S18">URLs</xref>.</p>
</fn>
<fn id="TFN7">
<label>‡</label>
<p id="P63"><italic>SATB2</italic> is significant both by focal deletions and as
part of the 2q33.1 region.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>